Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3011412	b-cd3	e6/l (—)	1244	3842	100.00%	Distribution not available
3011412	b-cd3	e9/l (e9/l)	1220	2432	0.70%
3011412	b-t-cd3	e9/l (e9/l)	758	1749	0.00%
3011412	b-t-cd3	— (—)	593	952	100.00%	Distribution not available
3011412	b-t-cd3	e6/l (e9/l)	577	1128	0.00%
3011412	b-cd3	— (—)	149	177	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malignant neoplasm

1090

1604

4.08

323.31

3.0

2.2

1.10

1.31

e9/l

2.72

980

1404

General symptoms and signs

1258

1691

3.77

315.83

2.6

2.2

1.21

1.20

e9/l

0.15

1123

1495

Explicit Sepsis

715

1380

4.96

314.98

2.9

2.3

1.14

1.20

e9/l

0.73

631

1243

Rare circulating lymphoid malignancy, including Hilmo

197

38.17

311.43

4.2

2.8

1.32

1.35

e9/l

0.06

173

Follicular lymphoma, hilmo

223

101

25.59

309.70

2.9

2.0

1.05

1.20

e9/l

0.67

209

ILD medications: prednisolone, methylprednisolone, prednisone

1762

1532

6.57

307.65

2.5

2.3

1.18

1.27

e9/l

2.30

1561

1361

Immunodeficiency with predominantly antibody defects

348

79.17

307.65

2.7

1.9

1.33

1.40

e9/l

0.18

310

Abnormal findings on diagnostic imaging of lung

737

1430

5.06

307.65

2.3

1.23

1.12

e9/l

0.40

673

1304

Other bacterial diseases

1480

2271

4.21

307.65

2.7

2.3

1.16

1.22

e9/l

1.73

1331

2002

Inflammatory bowel disease treatment related agents

1758

2063

4.85

307.65

2.3

2.6

1.17

1.24

e9/l

1.84

1561

1833

ILD medications

1942

1601

6.72

307.65

2.6

2.3

1.18

1.26

e9/l

2.59

1714

1417

Transplanted organ and tissue status

356

328

11.78

307.65

5.4

2.3

1.05

1.20

e9/l

1.60

323

288

Immunodeficiencies

441

141

40.54

307.65

2.8

2.4

1.35

1.34

e9/l

0.02

394

123

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1896

2079

6.46

307.65

2.6

2.3

1.19

1.25

e9/l

0.51

1697

1837

Other septicaemia

623

987

6.23

307.65

3.0

2.2

1.13

1.17

e9/l

0.50

549

884

Diffuse large B-cell lymphoma, including Hilmo

317

52.98

307.65

2.3

2.0

0.99

1.28

e9/l

1.75

290

Certain disorders involving the immune mechanism

710

653

11.76

307.65

2.9

2.4

1.23

1.19

e9/l

0.43

636

576

Bacterial infection, other or unspecified

1040

1326

7.02

307.65

2.8

2.3

1.18

e9/l

0.01

954

1194

1375

1571

5.40

307.65

2.4

2.3

1.25

1.17

e9/l

0.52

1242

1393

First line medication for Crohn's disease

1726

1620

5.87

307.65

2.6

2.4

1.17

1.28

e9/l

3.79

1531

1425

Non-Hodgkin lymphoma, all, including Hilmo

845

237

41.67

307.65

2.7

2.0

1.10

e9/l

0.04

769

212

Diffuse large B-cell lymphoma, helper endpoint

317

52.98

307.65

2.3

2.0

0.99

1.28

e9/l

1.75

290

Enlarged lymph nodes

568

394

15.46

307.65

2.7

2.2

1.10

1.26

e9/l

2.78

511

354

Other diseases of blood and blood-forming organs, wide

695

732

10.13

307.65

3.0

2.4

1.24

1.17

e9/l

0.20

628

649

Bacterial infection, other or unspecified

1076

1437

6.52

307.65

2.8

2.3

1.18

1.19

e9/l

0.03

989

1287

Non-follicular lymphoma

610

228

31.63

307.65

2.7

2.0

1.07

1.12

e9/l

0.34

556

199

Demyelinating diseases of the central nervous system

445

259

19.36

307.65

3.8

2.1

1.36

1.31

e9/l

0.38

398

227

L04AX Other immunosuppressants

988

2093

4.84

307.65

2.3

2.5

1.09

1.23

e9/l

4.79

874

1867

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

971

2037

4.36

307.65

2.4

1.24

1.15

e9/l

0.40

889

1828

Non-Hodgkin lymphoma, all

284

60.59

307.65

2.9

1.9

1.11

1.23

e9/l

0.41

252

Anaemias

490

349

9.46

307.65

3.1

2.3

1.12

1.39

e9/l

5.86

435

299

Secondary and unspecified malignant neoplasm of lymph nodes

474

147

37.24

307.65

2.6

1.9

1.03

1.16

e9/l

0.99

431

131

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1375

1571

5.40

307.65

2.4

2.3

1.25

1.17

e9/l

0.52

1242

1393

Fever of other and unknown origin

1182

1379

7.87

307.65

2.8

2.2

1.25

1.20

e9/l

0.29

1081

1218

L04AA Selective immunosuppressants

620

847

7.72

307.65

2.8

2.6

1.13

1.25

e9/l

1.83

540

752

Influenza and pneumonia

1563

2421

4.18

307.65

2.5

2.4

1.26

1.22

e9/l

0.22

1412

2126

Primary_lymphoid and hematopoietic malignant neoplasms

1253

559

25.16

307.65

3.1

2.1

1.12

1.09

e9/l

0.27

1142

505

Autoimmune diseases excluding thyroid diseases

1459

2089

3.87

307.65

2.5

2.4

1.18

1.27

e9/l

1.13

1316

1828

All pneumoniae

1504

2473

4.14

307.65

2.4

2.5

1.25

1.22

e9/l

0.17

1355

2174

Autoimmune diseases excluding thyroid diseases, strict definition

1422

2026

3.90

307.65

2.5

2.4

1.18

1.28

e9/l

1.13

1284

1774

Agranulocytosis

426

344

13.53

307.65

3.2

2.2

1.04

1.19

e9/l

1.71

392

308

Other bacterial diseases

1476

2191

4.62

307.65

2.8

2.3

1.20

1.21

e9/l

0.03

1327

1934

Secondary uncertain malignant neoplasm

516

229

24.63

307.65

2.6

2.1

1.02

1.12

e9/l

0.94

468

206

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1429

2504

3.96

307.65

2.4

2.5

1.26

1.21

e9/l

0.34

1287

2206

Oral corticosteroids

1729

1929

5.43

307.65

2.2

2.6

1.16

1.22

e9/l

1.35

1545

1722

Second line medication for Crohn's disease

1016

2170

4.80

307.65

2.3

2.5

1.08

1.23

e9/l

5.50

901

1936

MS-disease / Multiple Sclerosis

420

201

23.96

307.65

3.8

2.1

1.37

1.33

e9/l

0.25

375

178

Autoimmune diseases related-to ILD

1247

2621

4.14

307.65

2.6

2.3

1.20

1.24

e9/l

0.43

1121

2323

Pneumonias (Asthma/COPD co-morbidities)

1510

2413

4.28

307.65

2.4

2.5

1.25

1.21

e9/l

0.25

1360

2119

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

513

286

19.36

307.65

2.6

2.3

1.02

1.10

e9/l

0.77

467

258

Pneumonia, organism unspecified

1335

2208

4.32

307.65

2.4

2.5

1.27

1.21

e9/l

0.39

1208

1943

Diffuse large B-cell lymphoma

317

52.98

307.65

2.3

2.0

0.99

1.28

e9/l

1.75

290

Other and unspecified immunodeficiencies with predominantly antibody defects

189

103.42

307.65

3.0

1.4

1.35

1.55

e9/l

0.44

162

Liquid cancers, helper endpoint

1406

711

18.52

307.65

3.0

2.1

1.18

1.19

e9/l

0.04

1276

638

ILD medications: immunosuppressive drugs

1428

1419

9.68

307.65

2.7

2.3

1.10

1.26

e9/l

6.07

1269

1262

Septicaemia

695

1108

6.02

307.65

3.0

2.2

1.14

1.19

e9/l

0.66

614

991

Kela reimbursement Agammaglobulinemia (D80-84)

155

132.94

299.52

3.3

1.3

1.21

1.54

e9/l

0.70

139

Nonhereditary hypogammaglobulinemia

158

100.78

297.19

2.6

1.5

1.20

1.44

e9/l

0.53

143

Malignant neoplasm, wide definition for exclusion

1076

1673

3.83

292.83

3.0

2.3

1.11

1.32

e9/l

2.81

965

1463

ILD medications: azathioprine

321

313

10.69

290.34

2.4

2.2

1.05

1.26

e9/l

2.48

283

281

Aplastic and other anaemias

682

1387

4.69

281.44

2.7

2.3

1.10

1.18

e9/l

0.21

618

1245

Certain infectious and parasitic diseases

1075

1409

3.87

278.60

2.6

2.2

1.25

1.21

e9/l

0.65

948

1239

Bacterial pneumonia (organism specified)

676

1343

4.67

275.02

2.3

2.5

1.15

e9/l

0.01

602

1210

COPD/asthma related infections

1133

1571

3.65

272.83

2.4

2.3

1.25

1.17

e9/l

1.42

1004

1393

COPD/asthma/ILD related infections

1133

1571

3.65

272.83

2.4

2.3

1.25

1.17

e9/l

1.42

1004

1393

Other demyelinating diseases of the central nervous system

197

25.00

272.14

3.7

2.2

1.37

1.30

e9/l

0.32

173

GASTRO-related operations

883

1003

4.47

271.95

2.8

2.2

1.23

1.34

e9/l

2.24

785

839

Any gastric operation

883

1003

4.47

271.95

2.8

2.2

1.23

1.34

e9/l

2.24

785

839

Other and unspecified anaemias

619

1259

4.79

264.33

2.7

2.2

1.11

1.18

e9/l

0.19

558

1125

Other anaemias

622

1275

4.74

262.09

2.7

2.2

1.11

1.19

e9/l

0.21

561

1140

Other and unspecified types of non-Hodgkin lymphoma, hilmo

201

106

21.58

261.16

2.8

2.0

1.16

1.22

e9/l

0.19

188

ILD, hospital admission 2, with pulmonary infections

237

170

14.71

260.82

2.3

2.2

1.01

1.02

e9/l

0.05

219

154

Purpura and other haemorrhagic conditions

357

462

8.16

260.09

3.1

2.5

1.02

1.19

e9/l

2.21

319

414

Any event in cancer register

1086

1891

3.43

254.29

3.0

2.3

1.11

1.28

e9/l

6.68

976

1664

Viral infections characterized by skin and mucous membrane lesions

685

1653

4.24

254.01

2.6

1.23

1.21

e9/l

0.17

603

1456

Any reimbursement code in KELA

646

578

5.67

252.63

2.8

2.2

1.29

1.46

e9/l

3.16

560

493

Other degenerative diseases of the nervous system

489

599

6.26

252.03

3.7

2.1

1.32

1.10

e9/l

5.44

437

540

Drug-induced neutropenia

252

215

12.79

251.30

3.1

2.0

0.97

1.15

e9/l

1.59

241

197

Bacterial Sepsis

648

1251

4.52

248.81

2.5

2.3

1.12

1.17

e9/l

0.44

578

1135

Pneumonia due to other infectious organisms, not elsewhere classified

172

27.33

245.83

3.0

2.2

1.01

1.17

e9/l

1.14

167

Autoimmune diseases

1264

2105

3.09

239.83

2.5

2.4

1.19

1.28

e9/l

0.91

1139

1841

Dental caries

455

785

5.73

237.57

3.1

2.2

1.17

1.18

e9/l

0.03

393

700

Thrombocytopenia, unspecified

238

209

12.32

232.65

3.3

2.3

1.00

1.19

e9/l

1.52

214

183

Protozoal diseases

171

24.55

232.43

3.0

2.0

1.05

1.29

e9/l

0.99

166

Azathioprine

321

417

8.01

232.39

2.4

2.7

1.05

1.24

e9/l

2.40

283

376

Infections, IBD-co-morbidities

319

237

9.92

230.19

3.2

2.3

1.34

1.14

e9/l

1.73

286

207

Asthma (only as main-diagnosis)

728

989

4.31

229.47

1.9

2.5

1.29

1.20

e9/l

1.59

639

869

Asthma (only as main-diagnosis), excluding more controls

717

955

4.34

226.87

1.9

2.5

1.29

1.21

e9/l

1.25

628

839

Lymphoid leukaemia

213

165

14.21

225.72

3.7

2.2

1.37

1.24

e9/l

0.59

190

143

Coagulation defects, purpura and other haemorrhagic conditions

412

725

5.91

223.56

3.0

2.5

1.03

1.21

e9/l

3.12

365

641

Bacterial pneumoniae

539

1018

4.76

223.04

2.2

2.4

1.21

1.15

e9/l

0.70

468

905

Asthma

773

989

4.14

222.90

2.0

2.5

1.28

1.20

e9/l

1.21

676

869

Asthma, excluding more controls

756

955

4.18

219.48

2.0

2.5

1.29

1.21

e9/l

1.12

661

839

ILD, hospital admissions 3, with pneumonia sepsis

211

169

13.21

217.76

2.4

2.2

1.02

1.13

e9/l

0.76

197

149

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

259

150

12.76

215.03

2.3

1.04

1.16

e9/l

0.77

238

136

Used for control exclusion in common control thyroid runs

1155

1955

3.02

210.76

2.6

2.4

1.19

1.28

e9/l

0.89

1035

1710

Implicit bacterial Sepsis

538

1077

4.51

209.24

2.5

2.3

1.10

1.13

e9/l

0.21

484

989

Asthma (mode)

742

1000

4.02

207.97

2.1

2.5

1.28

1.20

e9/l

1.17

649

878

Bacterial pneumonia, not elsewhere classified

500

945

4.75

206.41

2.1

2.4

1.21

1.14

e9/l

0.81

429

840

L04AD Calcineurin inhibitors

309

443

7.41

206.11

3.5

2.7

1.07

1.28

e9/l

2.46

270

393

Viral infections characterized by skin and mucous membrane lesions

1035

3103

2.89

205.36

2.5

2.4

1.27

1.21

e9/l

0.27

916

2757

Implicit bacterial Sepsis

564

1164

4.26

202.41

2.5

2.3

1.11

1.14

e9/l

0.26

505

1065

Caries of dentine

393

700

5.62

201.81

2.8

2.3

1.16

1.15

e9/l

0.06

346

627

Viral Sepsis

354

596

6.13

200.71

2.5

2.3

1.19

1.18

e9/l

0.02

311

539

Bronchitis

1188

2746

2.75

199.23

2.6

2.3

1.24

1.21

e9/l

0.33

1051

2458

Implicit viral Sepsis

351

594

6.09

197.96

2.5

2.3

1.18

e9/l

0.00

308

537

Other pulmonary diagnosis

763

1004

3.85

197.00

2.5

1.25

1.20

e9/l

0.52

675

883

COPD differential diagnosis

760

1000

3.85

196.23

2.5

1.25

1.20

e9/l

0.55

673

878

ILD differential diagnosis

760

1000

3.85

196.22

2.5

1.25

1.20

e9/l

0.55

673

878

Excluding asthma or asthma-COPD overlap

761

1004

3.84

195.82

2.5

1.25

1.20

e9/l

0.52

673

883

Systemic connective tissue disorders

511

1219

4.29

192.79

2.3

2.4

1.13

1.19

e9/l

0.75

465

1091

Persons encountering health services for specific procedures and health care

1213

2731

2.69

192.09

2.3

2.5

1.16

1.28

e9/l

2.11

1082

2416

Asthma, unspecified (mode)

529

913

4.42

190.49

2.1

2.5

1.25

1.19

e9/l

0.70

474

806

Asthma, unspecified (mode), excluding more controls

522

886

4.46

189.88

2.1

2.5

1.26

1.20

e9/l

0.64

467

782

Other disorders of white blood cells

180

141

13.84

189.05

3.2

2.4

1.69

1.13

e9/l

0.50

156

132

Oxycodone

509

1089

4.31

188.02

2.4

1.15

1.12

e9/l

0.27

465

994

Solid cancers, helper endpoint

855

1563

3.27

187.10

2.5

2.2

1.05

1.31

e9/l

3.53

761

1371

1161

2182

2.78

185.59

2.5

2.3

1.25

1.20

e9/l

0.46

1024

1953

Non-invasive ventilation

377

632

5.45

182.43

2.4

2.8

1.18

1.16

e9/l

0.13

347

559

Implicit viral Sepsis

413

895

4.72

176.03

2.4

2.2

1.18

1.20

e9/l

0.23

361

809

Acute sinusitis

639

1738

3.45

174.59

2.7

2.3

1.31

1.19

e9/l

2.78

555

1562

Other medical care

560

1354

3.78

173.38

2.1

2.6

1.01

1.25

e9/l

2.51

504

1212

Zoster [herpes zoster]

313

548

5.90

170.55

2.7

2.3

1.17

1.14

e9/l

0.23

276

495

Asthma-related pneumonia

512

1335

3.91

170.38

1.9

2.5

1.28

1.16

e9/l

2.03

452

1184

Acute upper respiratory infections of multiple and unspecified sites

851

2158

2.96

169.99

2.8

2.3

1.24

1.18

e9/l

1.19

751

1931

Asthma, hospital admissions 3, pneumonia

512

1341

3.89

169.28

1.9

2.5

1.28

1.17

e9/l

1.98

452

1189

Asthma-related pneumonia or sepsis

512

1341

3.89

169.28

1.9

2.5

1.28

1.17

e9/l

1.98

452

1189

Other and unspecified disorders of white blood cells

148

101

16.09

168.48

3.6

2.4

1.80

1.17

e9/l

0.45

131

Asthma-related infections

732

2366

3.07

167.53

1.9

2.6

1.32

1.17

e9/l

4.31

640

2096

Asthma, hospital admission 2, infections

732

2366

3.07

167.53

1.9

2.6

1.32

1.17

e9/l

4.31

640

2096

Other respiratory diseases principally affecting the interstitium

304

533

5.89

165.43

2.2

2.1

1.01

1.10

e9/l

0.91

281

480

Neoplasms

822

1396

3.15

164.06

3.0

2.3

1.20

1.35

e9/l

4.23

710

1218

Hodgkin lymphoma, hilmo

130

19.51

161.77

2.4

2.3

0.96

1.34

e9/l

1.63

121

Optic neuritis

150

113

14.45

161.34

3.6

2.4

1.30

1.31

e9/l

0.03

132

106

Fungal Sepsis

137

16.20

157.11

2.4

2.1

1.12

1.07

e9/l

0.25

123

Interstitial lung disease endpoints

272

454

6.21

155.92

2.3

2.0

1.00

1.12

e9/l

1.24

252

404

Interstitial lung disease

272

454

6.21

155.92

2.3

2.0

1.00

1.12

e9/l

1.24

252

404

Other interstitial pulmonary diseases

272

455

6.19

155.57

2.3

2.0

1.00

1.11

e9/l

1.21

252

406

ILD, hospital admissions

270

449

6.23

155.38

2.3

2.0

1.00

1.12

e9/l

1.29

250

400

Implicit fungal Sepsis

131

17.04

154.02

2.5

2.0

1.08

1.07

e9/l

0.04

117

Implicit fungal Sepsis

161

147

11.57

152.82

2.3

1.12

1.10

e9/l

0.12

141

135

Cytomegalovirus infection, IBD co-morbidity

122

19.95

151.80

4.2

2.1

1.42

1.12

e9/l

1.38

112

Acute upper respiratory infections

1049

2563

2.54

150.61

2.6

2.3

1.25

1.20

e9/l

0.58

917

2299

Bronchiectasis

186

212

9.26

150.40

1.9

2.0

1.25

1.13

e9/l

0.96

158

191

Cytomegaloviral disease

122

19.00

148.62

4.2

2.1

1.42

1.20

e9/l

0.85

112

Implicit Sepsis

769

2043

2.87

146.68

2.3

2.4

1.13

1.23

e9/l

0.89

683

1843

All influenza

342

744

4.69

145.14

2.6

2.7

1.25

1.17

e9/l

0.82

308

645

Reimbursement for rheumatic diseases

656

2223

2.98

142.96

2.0

2.6

1.08

1.24

e9/l

2.14

593

1978

Provisional assignment of new diseases of uncertain etiology

626

2088

3.04

141.08

2.2

2.4

1.23

1.21

e9/l

0.22

547

1857

Headache

607

1538

3.18

140.72

2.4

2.2

1.38

1.21

e9/l

4.72

545

1357

Use of glatiramer acetate

100

26.69

140.55

4.1

2.7

1.26

1.23

e9/l

0.10

Codes for special purposes

626

2093

3.03

140.49

2.2

2.4

1.23

1.21

e9/l

0.24

547

1861

Zoster [herpes zoster]

542

1647

3.29

139.20

2.6

2.3

1.27

1.17

e9/l

0.25

487

1487

Disorders of optic nerve and visual pathways

218

332

6.88

137.19

3.4

2.3

1.35

1.30

e9/l

0.23

191

290

Multiple myeloma, including Hilmo

107

19.94

137.07

3.0

1.9

1.04

1.20

e9/l

0.62

Other acute lower respiratory infections

630

2034

2.99

136.97

2.5

1.28

1.20

e9/l

1.22

562

1785

570

1830

3.14

135.64

1.9

2.7

1.36

1.22

e9/l

3.45

495

1604

Covid-19 confirmed case

465

1330

3.56

135.55

2.3

2.4

1.27

1.18

e9/l

1.05

411

1184

Certain infectious and parasitic diseases

661

1033

3.23

134.60

2.6

2.2

1.23

1.19

e9/l

0.44

575

906

Diagnoses used for exclusion with ILD

359

862

4.26

134.49

2.2

2.4

0.96

1.18

e9/l

5.25

334

778

Viral pneumonia

217

337

6.64

133.51

2.5

2.6

1.01

1.19

e9/l

2.28

194

286

Selective deficiency of immunoglobulin G [IgG] subclasses

52.35

133.29

2.2

1.9

1.35

1.38

e9/l

0.04

Medical observation and evaluation for suspected diseases and conditions

644

1028

3.23

132.21

3.0

2.0

1.27

1.11

e9/l

3.33

563

919

Failure and rejection of transplanted organs and tissues

25.63

131.07

8.7

2.3

0.92

1.18

e9/l

0.97

Herpesviral [herpes simplex] infections

227

379

6.22

130.25

2.6

2.5

1.27

1.23

e9/l

0.20

202

342

Other/unspecified cytomegaloviral diseases

106

19.33

129.62

4.4

2.0

1.43

1.15

e9/l

1.04

Common variable immunodeficiency

53.37

129.55

2.2

1.3

1.10

1.43

e9/l

0.65

Undetermined asthma

179

232

7.90

129.47

2.1

2.5

1.38

1.12

e9/l

3.47

158

203

General examination and investigation of persons without complaint and reported diagnosis

625

1028

3.20

127.44

2.9

2.0

1.23

1.11

e9/l

2.35

562

919

Undetermined asthma, excluding more controls

179

238

7.70

126.66

2.1

2.5

1.38

1.11

e9/l

3.58

158

211

Other immunodeficiencies

31.70

126.62

2.6

1.8

1.46

1.45

e9/l

0.02

Use of interferon beta-1a

105

18.17

126.19

3.8

2.5

1.19

1.29

e9/l

0.38

Other special examinations and investigations of persons without complaint or reported diagnosis

635

1028

3.16

125.19

2.6

2.0

1.26

1.11

e9/l

3.20

561

919

ILD, hospital admissions 1, main diag only

231

410

5.83

124.33

2.2

2.0

0.99

1.14

e9/l

1.60

214

364

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

995

2768

2.36

124.13

3.2

2.2

1.18

1.26

e9/l

1.02

891

2441

Symptoms and signs involving the skin and subcutaneous tissue

740

2842

2.58

121.99

2.7

2.3

1.22

1.21

e9/l

0.07

650

2546

Mycoses

368

970

3.88

121.31

2.6

2.4

1.20

1.19

e9/l

0.08

326

862

Chronic sinusitis

497

1587

3.17

121.08

2.1

2.5

1.32

1.11

e9/l

6.76

423

1428

Implicit Sepsis

786

2260

2.57

120.43

2.3

2.4

1.14

1.24

e9/l

1.08

697

2030

Other disorders involving the immune mechanism, not elsewhere classified

111

13.80

115.94

5.2

2.1

1.31

1.27

e9/l

0.10

Other diseases of pleura

481

1330

3.22

115.89

2.3

2.4

1.02

1.15

e9/l

2.31

435

1208

Asthma and opportunity respiratory infection

123

115

11.43

115.18

1.6

2.1

1.41

1.05

e9/l

3.19

101

Polyarthropathies

730

1828

2.64

114.39

2.2

2.6

1.13

1.16

e9/l

0.31

659

1626

Sarcoidosis

222

412

5.57

113.87

2.4

0.91

1.17

e9/l

4.02

206

368

Other systemic involvement of connective tissue (FG)

316

770

4.13

113.55

2.3

2.5

1.17

1.21

e9/l

0.34

286

694

Mature T/NK-cell lymphomas, hilmo

26.79

113.51

3.4

1.9

1.41

1.16

e9/l

0.47

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

106

14.01

111.59

5.4

2.1

1.32

1.25

e9/l

0.20

Malaise and fatigue

443

1077

3.34

111.53

2.1

2.2

1.21

1.20

e9/l

0.07

389

961

Renal failure

471

1376

3.07

105.22

2.5

2.3

1.08

1.14

e9/l

0.69

441

1238

Abnormalities of breathing

872

2189

2.33

102.95

2.1

2.6

1.27

1.20

e9/l

1.15

769

1934

Explicit bacterial Sepsis

170

269

6.51

102.75

2.7

2.5

1.20

1.16

e9/l

0.21

151

243

Dermatitis

625

2459

2.56

102.27

2.5

2.4

1.21

1.20

e9/l

0.05

556

2187

Other and unspecified dermatitis

550

2047

2.72

101.63

2.6

2.4

1.23

1.21

e9/l

0.13

485

1820

Neurological diseases

835

1756

2.41

101.10

2.8

2.3

1.32

1.17

e9/l

4.10

732

1541

Condition for Implicit Sepsis (Organ dysfunction codes)

780

2339

2.37

100.71

2.3

2.4

1.13

1.24

e9/l

1.48

690

2101

Diseases of the respiratory system

529

868

3.08

100.16

2.3

1.25

1.18

e9/l

0.70

458

767

Streptococcal septicaemia

140

185

7.82

99.94

2.8

2.5

1.20

1.15

e9/l

0.19

126

164

Acute bronchitis

459

1533

2.98

99.71

2.5

1.28

1.20

e9/l

1.25

416

1338

Other systemic involvement of connective tissue

334

942

3.61

99.70

2.3

2.4

1.16

1.20

e9/l

0.29

303

842

Herpesviral [herpes simplex] infections

320

878

3.72

99.56

2.5

2.6

1.29

1.25

e9/l

0.39

279

774

Renal tubulo-interstitial diseases

832

2756

2.27

98.03

2.5

2.4

1.17

1.22

e9/l

0.50

757

2444

Asthma (diagnoses ohter than nonallergic)

847

3192

2.22

97.14

2.0

2.5

1.28

1.21

e9/l

1.00

739

2846

All kidney diseases

936

2978

2.16

96.76

2.5

2.4

1.17

1.24

e9/l

0.93

846

2635

Malignant neoplasm of eye, brain and central nervous system

12.63

96.64

1.9

2.2

1.06

1.34

e9/l

1.33

Osteopathies and chondropathies

566

2027

2.63

96.53

2.5

2.4

1.18

1.21

e9/l

0.28

511

1804

Cough

441

1418

2.98

95.41

2.6

1.21

1.17

e9/l

0.39

389

1249

Oedema, not elsewhere classified

286

737

3.88

94.91

2.4

2.2

1.15

1.17

e9/l

0.14

246

667

SLE (Finngen)

15.15

92.73

2.5

3.2

0.88

1.22

e9/l

1.10

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

297

339

4.43

91.39

2.8

2.0

1.28

1.30

e9/l

0.12

262

290

All chronic kidney diseases

547

1714

2.64

91.18

2.4

2.5

1.12

1.17

e9/l

0.63

506

1510

Dyspnoea

833

2824

2.20

90.98

2.1

2.5

1.20

1.21

e9/l

0.10

745

2523

Multiple myeloma and malignant plasma cell neoplasms

111

125

9.40

90.75

3.0

2.0

1.06

1.13

e9/l

0.26

101

113

Other viral diseases

394

1302

3.07

90.48

3.3

2.6

1.32

1.29

e9/l

0.23

351

1113

Intestinal infectious diseases

895

3224

2.12

90.22

2.5

2.4

1.26

1.22

e9/l

0.39

785

2873

Chronic kidney disease

320

918

3.47

89.79

2.4

2.2

1.08

1.12

e9/l

0.36

301

822

Condition for Implicit Sepsis (Organ dysfunction codes)

796

2476

2.23

89.06

2.3

2.4

1.14

1.25

e9/l

1.40

699

2221

Malignant neoplasm of brain

13.74

87.67

1.9

2.1

1.01

1.42

e9/l

2.10

Other viral diseases

460

1673

2.77

87.66

3.1

2.6

1.32

1.27

e9/l

0.44

405

1448

Enterocolitis due to Clostridium difficile

164

296

5.70

86.71

2.8

2.3

1.20

1.16

e9/l

0.17

148

272

Diseases of the skin and subcutaneous tissue

884

2049

2.18

85.70

2.5

2.4

1.27

1.22

e9/l

0.40

774

1823

Methotrexate

170

322

5.39

85.09

1.9

2.7

1.15

1.18

e9/l

0.12

154

294

Complications of medical and surgical care

681

2773

2.28

84.94

3.0

2.2

1.19

1.20

e9/l

0.06

615

2483

Osteoporosis

278

713

3.71

84.88

2.5

2.2

1.06

1.14

e9/l

0.74

253

637

Dermatitis and eczema

1007

3115

2.02

84.88

2.5

2.4

1.26

1.21

e9/l

0.52

901

2769

Heart failure, not strict

682

1996

2.34

84.71

2.3

2.5

1.05

1.21

e9/l

2.15

616

1805

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1003

2685

2.04

84.67

2.4

2.5

1.20

1.22

e9/l

0.18

910

2365

Malignant neoplasm of brain, including Hilmo

103

9.94

84.17

2.1

2.3

1.01

1.32

e9/l

1.98

Asthma, hospital admissions , main diagnosis only

773

3194

2.15

83.28

1.9

2.6

1.31

1.21

e9/l

1.59

677

2843

Opioids

849

2044

2.17

82.58

2.4

1.30

1.18

e9/l

2.91

751

1822

Other bacterial intestinal infections

227

561

4.13

82.02

2.8

2.5

1.21

1.14

e9/l

0.53

203

507

Neurological diseases, wide definition

317

422

3.81

81.45

3.0

2.1

1.36

1.30

e9/l

0.42

271

341

Other disorders of lacrimal gland

377

1299

2.94

80.84

3.0

2.3

1.18

1.17

e9/l

0.03

355

1157

Other reaction to severe stress, and adjustment disorders

411

1490

2.79

80.13

3.1

2.5

1.31

1.24

e9/l

0.95

376

1312

Finngen Rheumatological endpoints

862

2344

2.11

79.68

2.3

2.6

1.20

1.23

e9/l

0.45

768

2081

Other necrotizing vasculopathies (FG)

112

151

7.72

78.78

2.4

2.1

1.12

1.10

e9/l

0.08

104

136

Complications of surgical and medical care, not elsewhere classified

878

2959

2.05

78.78

2.8

2.3

1.19

1.22

e9/l

0.27

792

2638

Chronic lower respiratory diseases

1076

2972

1.94

78.36

2.1

2.6

1.28

1.22

e9/l

0.77

938

2654

Tramadol

671

1806

2.30

78.18

2.1

2.4

1.27

1.16

e9/l

2.08

603

1621

Candidiasis

199

463

4.41

78.06

2.4

2.3

1.27

1.20

e9/l

0.42

176

412

Symptoms and signs involving the nervous and musculoskeletal systems

560

2385

2.37

77.87

2.8

2.4

1.35

1.16

e9/l

4.38

510

2113

Persons encountering health services in other circumstances, wide

1024

2687

1.97

77.66

2.4

2.5

1.18

1.22

e9/l

0.33

934

2366

Acute renal failure

241

648

3.79

77.35

2.6

2.2

0.99

1.11

e9/l

1.27

226

582

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

12.11

76.87

2.7

2.3

1.37

1.16

e9/l

0.64

Other necrotizing vasculopathies

124

193

6.67

76.43

2.4

2.0

1.09

1.15

e9/l

0.26

113

177

Idiopathic thrombocytopenic purpura

11.24

75.92

2.8

2.2

1.22

1.31

e9/l

0.20

Gastrointestinal diseases

540

1055

2.58

75.55

2.6

2.4

1.28

1.23

e9/l

0.44

466

923

Encephalitis

11.09

74.36

3.1

2.1

1.29

1.07

e9/l

1.18

Systemic lupus erythematosus

10.57

74.07

2.5

2.6

0.88

1.12

e9/l

1.50

Bacterial intestinal infections, IBD co-morbidities

225

596

3.85

73.86

2.8

2.5

1.21

1.10

e9/l

0.95

201

535

Candidiasis

325

1087

3.04

73.60

2.4

1.36

1.22

e9/l

1.58

283

958

Examination and observation for other reasons

469

1024

2.67

73.20

2.5

2.0

1.34

1.11

e9/l

4.40

396

915

Disorders of lacrimal system

421

1618

2.63

72.79

2.9

2.3

1.18

1.22

e9/l

0.26

392

1433

Dialysis, with operation codes

184

426

4.44

72.71

2.6

2.7

1.02

1.18

e9/l

1.26

164

376

Other encephalitis

11.14

72.62

3.1

2.1

1.28

1.11

e9/l

0.76

Pain, not elsewhere classified

250

720

3.51

72.25

2.2

2.3

1.38

1.25

e9/l

1.24

225

641

Diarrhoea and gastroenteritis of presumed infectious origin

657

2757

2.16

72.16

2.4

1.26

1.20

e9/l

0.80

573

2448

Infections of the skin and subcutaneous tissue

576

2548

2.26

71.61

2.5

1.22

1.21

e9/l

0.08

510

2253

Cardiovascular diseases (excluding rheumatic etc)

646

1652

2.27

71.58

2.4

2.7

1.25

1.31

e9/l

0.71

564

1436

Inflammatory diseases of the central nervous system

143

275

5.38

70.73

2.5

1.31

1.24

e9/l

0.35

127

248

Care involving use of rehabilitation procedures

560

2274

2.28

70.47

2.3

2.6

1.24

1.26

e9/l

0.15

480

2011

Disorders of other endocrine glands

452

1815

2.48

69.05

2.6

2.5

1.23

1.24

e9/l

0.15

410

1591

Other symptoms and signs involving the nervous and musculoskeletal systems

422

1671

2.55

69.01

3.0

2.5

1.33

1.20

e9/l

2.13

389

1480

Seropositive rheumatoid arthritis

252

754

3.38

68.25

2.0

2.4

1.00

1.20

e9/l

3.49

227

685

Any death

541

1678

2.33

67.53

2.2

2.4

1.15

1.14

e9/l

0.01

493

1532

Parasetamol

648

1476

2.24

67.42

2.5

1.24

1.19

e9/l

0.66

558

1310

Nephropathy related operations

179

431

4.27

67.27

2.6

2.5

1.05

1.17

e9/l

0.87

160

379

Diseases of the eye and adnexa

736

1747

2.12

67.27

2.9

2.4

1.30

1.20

e9/l

1.83

650

1541

Rheumatoid arthritis

317

973

2.96

67.10

2.0

2.4

1.03

1.13

e9/l

1.25

286

877

Other and unspecified aplastic anaemias

22.16

66.99

2.3

1.8

0.99

1.13

e9/l

0.28

Erysipelas

407

1406

2.58

66.60

2.1

2.2

1.17

1.16

e9/l

0.06

361

1274

Erysipelas

511

1670

2.35

66.34

2.1

2.3

1.17

e9/l

0.00

451

1499

Viral pneumonia (known virus, not influenza)

10.86

65.95

3.0

2.5

1.09

1.24

e9/l

0.53

Nutritional anaemias

444

1769

2.44

65.70

2.5

2.3

1.07

1.18

e9/l

2.08

400

1578

Nausea and vomiting

289

944

3.04

65.48

2.6

2.5

1.26

1.22

e9/l

0.27

256

826

Cardiovascular diseases

604

1446

2.26

65.46

2.5

2.8

1.30

1.32

e9/l

0.21

525

1262

Symptoms and signs involving the circulatory and respiratory systems

857

2196

1.97

64.04

2.4

2.6

1.29

1.20

e9/l

1.89

759

1941

ILD-related respiratory insufficiency

10.43

63.64

2.1

2.2

0.92

1.26

e9/l

1.16

Adrenocortical insufficiency

8.74

63.48

1.8

2.3

1.32

1.19

e9/l

0.41

Hernia of abdominal wall, postoperative

136

276

4.99

62.88

2.4

2.0

2.03

1.24

e9/l

0.59

125

243

Allergic asthma (mode)

197

518

3.76

62.84

1.9

2.6

1.37

1.20

e9/l

2.15

163

438

Diseases of oesophagus, stomach and duodenum

901

2867

1.89

62.83

2.1

2.5

1.22

e9/l

0.03

811

2545

Allergic asthma (mode), excluding more controls

197

522

3.73

62.13

1.9

2.6

1.37

1.21

e9/l

1.93

163

443

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

146

320

4.69

61.92

6.2

2.3

1.04

1.18

e9/l

1.16

135

292

Persons encountering health services for examination and investigation

496

1028

2.43

61.88

2.6

2.0

1.23

1.11

e9/l

1.73

428

919

Sulfasalazine

236

729

3.27

61.12

2.0

2.7

1.15

1.24

e9/l

0.58

207

664

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

304

698

2.98

60.70

2.1

1.12

1.25

e9/l

0.42

267

627

Codeine

739

2004

2.02

60.43

2.3

2.4

1.30

1.18

e9/l

2.69

656

1790

Other bacterial intestinal infections

247

793

3.16

60.14

2.9

2.5

1.22

1.17

e9/l

0.29

221

710

Iron deficiency anaemia

387

1551

2.48

59.67

2.5

2.4

1.08

1.19

e9/l

1.83

348

1381

Other malignant neoplasms of skin (=non-melanoma skin cancer)

283

639

3.06

59.40

2.1

1.11

1.26

e9/l

0.44

247

576

Other diseases of the respiratory system

217

654

3.37

58.66

2.3

2.4

1.07

1.10

e9/l

0.17

188

588

Other respiratory disorders and diseases

217

654

3.37

58.66

2.3

2.4

1.07

1.10

e9/l

0.17

188

588

Visual disturbances and blindness

474

2126

2.25

58.55

2.5

2.4

1.30

1.18

e9/l

2.31

423

1889

Early onset COPD, excluding more controls

151

354

4.31

58.42

1.7

2.4

1.30

1.08

e9/l

2.08

132

325

Venous thromboembolism

445

1875

2.31

58.36

2.3

1.35

1.14

e9/l

0.48

405

1700

Other specified/unspecified systemic involvement of connective tissue

155

6.49

58.33

2.1

2.4

1.07

1.17

e9/l

0.47

138

Pulmonary heart disease, diseases of pulmonary circulation

294

1059

2.81

58.17

2.3

1.49

1.13

e9/l

0.60

273

956

Unspecified acute lower respiratory infection

188

523

3.67

57.60

2.5

2.6

1.32

1.19

e9/l

1.13

161

461

Abnormal findings on diagnostic imaging of central nervous system

133

6.96

57.12

2.8

2.6

1.38

1.32

e9/l

0.16

116

Other heart diseases

461

1296

2.34

57.08

2.4

2.9

1.11

1.26

e9/l

3.35

409

1130

Gout, FINNGEN

251

836

3.03

57.00

2.5

2.1

1.06

e9/l

0.01

228

762

Rheumatoid arthritis, including avohilmo

350

1391

2.54

56.95

1.9

2.4

1.04

1.20

e9/l

2.85

312

1251

Malignant neoplasm of skin

306

747

2.83

56.08

2.1

1.12

1.25

e9/l

0.49

269

672

Gout

251

732

3.05

56.06

2.5

2.4

1.06

1.09

e9/l

0.17

228

671

Other disorders of skin and subcutaneous tissue

575

2494

2.06

55.93

2.3

2.4

1.20

1.18

e9/l

0.09

514

2237

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

510

2378

2.13

55.20

3.3

2.2

1.17

1.19

e9/l

0.13

464

2127

Mixed connective tissue disease

104

188

5.72

55.15

2.2

2.3

1.04

1.29

e9/l

1.66

169

Other diseases of intestines

904

2847

1.82

55.09

2.4

2.5

1.25

1.21

e9/l

0.72

789

2527

Care involving dialysis

115

231

5.12

54.17

2.4

2.9

1.03

1.22

e9/l

1.01

109

203

Visual disturbances

440

1979

2.24

54.13

2.5

2.4

1.30

1.18

e9/l

2.07

391

1755

Abnormal findings on examination of blood, without diagnosis

423

1712

2.29

53.71

2.5

2.4

1.14

1.15

e9/l

0.04

373

1551

Non-allergic asthma (mode), excluding more controls

152

378

4.03

53.60

1.6

2.4

1.22

1.16

e9/l

0.38

131

322

Intestinal infectious diseases

944

3055

1.77

53.43

2.5

2.4

1.27

1.21

e9/l

0.72

832

2730

Disorders of eyelid, lacrimal system and orbit

707

2834

1.91

53.36

2.7

2.4

1.20

e9/l

0.03

655

2528

Noninfective enteritis and colitis

444

2021

2.21

52.86

2.4

2.6

1.21

1.22

e9/l

0.09

403

1773

Pulmonary heart disease

267

964

2.80

52.67

2.3

1.53

1.14

e9/l

0.57

248

872

Pulmonary embolism

267

964

2.80

52.67

2.3

1.53

1.13

e9/l

0.59

248

872

Non-allergic asthma (mode)

152

383

3.97

52.65

1.6

2.4

1.22

1.15

e9/l

0.43

131

327

Drug-induced adrenocortical insufficiency

10.70

52.32

1.6

2.0

1.34

1.23

e9/l

0.24

Other disorders of skin and subcutaneous tissue, not elsewhere classified

167

458

3.72

52.30

2.5

2.4

1.22

1.14

e9/l

0.49

153

414

Asthma, including avohilmo

977

3157

1.75

52.26

2.1

2.6

1.28

1.21

e9/l

0.99

854

2823

Respiratory insufficiency

114

7.04

51.91

1.8

2.5

1.17

1.08

e9/l

0.34

104

Other arthritis (FG)

284

1067

2.69

51.88

2.1

2.6

1.55

1.22

e9/l

0.49

258

957

Asthma/COPD (KELA code 203)

786

2960

1.83

51.33

2.0

2.6

1.28

1.22

e9/l

0.70

680

2645

Dermatitis due to substances taken internally

153

6.08

50.89

2.7

2.4

1.17

1.11

e9/l

0.24

137

Depression medications

238

365

3.30

50.68

2.5

2.2

1.31

1.32

e9/l

0.04

206

313

Lung cancer and mesothelioma

135

269

4.34

50.34

1.8

2.2

0.94

1.06

e9/l

0.97

129

246

DVT of lower extremities and pulmonary embolism

342

1425

2.41

49.77

2.3

1.46

1.14

e9/l

0.59

314

1294

Haemolytic anaemias

100

7.55

49.50

3.6

2.4

1.10

1.25

e9/l

0.54

Other disorders of adrenal gland

144

6.22

49.49

1.9

2.6

1.32

1.25

e9/l

0.22

123

Other skin changes

194

607

3.25

49.47

2.7

2.3

1.20

1.16

e9/l

0.29

172

552

Seropositive rheumatoid arthritis, wide

252

914

2.79

49.39

2.0

2.3

1.00

1.18

e9/l

3.03

227

822

Hypothyroidism (congenital or acquired)

208

344

3.44

49.18

2.4

2.3

1.29

1.34

e9/l

0.35

180

295

Other disorders of fluid, electrolyte and acid-base balance

274

985

2.68

49.09

2.0

2.4

1.48

1.12

e9/l

0.54

254

890

Other specified/unspecified arthritis

258

952

2.74

48.89

2.1

2.5

1.59

1.17

e9/l

0.59

234

848

Symptoms and signs involving the digestive system and abdomen

817

2260

1.82

48.80

2.7

2.4

1.22

1.18

e9/l

0.69

710

2005

Polyneuropathies and other disorders of the peripheral nervous system

219

743

2.99

48.60

3.2

2.4

1.27

1.11

e9/l

1.82

196

673

Idiopathic pulmonary fibrosis

185

5.38

48.45

1.7

2.1

1.04

1.12

e9/l

0.29

169

Other noninfective gastroenteritis and colitis

265

996

2.69

48.42

2.5

2.6

1.30

1.23

e9/l

0.61

239

860

Other/unspecified seropositive rheumatoid arthritis

248

902

2.79

48.36

1.9

2.3

1.00

1.18

e9/l

2.75

223

811

Gastro-oesophageal reflux disease

558

2447

1.98

48.34

2.2

2.5

1.30

1.19

e9/l

1.12

515

2180

Secondary thrombocytopenia

15.13

48.27

2.9

2.1

0.90

1.13

e9/l

0.48

Osteoporosis with pathological fracture (FG)

147

6.00

48.26

2.2

1.8

1.04

1.13

e9/l

0.38

130

Urticaria and erythema

363

1584

2.32

48.12

2.4

2.7

1.30

1.25

e9/l

0.49

306

1388

Diarrhoea and gastroenteritis of presumed infectious origin

817

3048

1.78

47.99

2.4

1.28

1.20

e9/l

1.04

714

2724

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

246

895

2.78

47.95

1.9

2.3

1.00

1.18

e9/l

2.86

221

805

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

158

437

3.61

47.67

1.8

2.1

0.90

1.10

e9/l

2.77

150

395

Other heart diseases, wide

774

2632

1.81

47.45

2.3

2.6

1.14

1.28

e9/l

2.41

680

2333

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

103

211

5.01

47.43

2.5

2.0

1.19

1.13

e9/l

0.25

192

Other and unspecified iron deficiency

304

1233

2.49

47.41

2.6

2.4

1.13

1.19

e9/l

0.61

273

1098

Haemorrhage from respiratory passages

279

970

2.62

47.31

2.4

1.50

1.10

e9/l

0.58

245

876

Malignant neoplasm of respiratory system and intrathoracic organs

137

280

4.11

47.24

2.0

1.9

0.93

1.09

e9/l

1.65

129

253

Hypothyroidism and >3 levothyroxin purchases

204

343

3.39

47.20

2.3

1.29

1.33

e9/l

0.28

176

294

Hypothyroidism, levothyroxine purchases

204

343

3.39

47.20

2.3

1.29

1.33

e9/l

0.28

176

294

Syncope and collapse

291

978

2.56

46.96

2.4

2.2

1.20

1.19

e9/l

0.08

252

881

Symptoms and signs concerning food and fluid intake

109

236

4.69

46.75

2.8

2.0

1.36

1.28

e9/l

0.35

210

Factors influencing health status and contact with health services

210

312

3.40

46.69

2.6

2.1

1.28

1.11

e9/l

1.42

189

284

Glomerular diseases

199

655

3.09

46.64

2.0

2.6

1.16

1.15

e9/l

0.05

185

583

Procreative management

353

1272

2.34

46.19

2.4

2.6

1.35

1.26

e9/l

0.97

296

1113

Symptoms and signs involving the urinary system

617

2496

1.90

45.90

2.8

2.4

1.25

1.20

e9/l

0.42

558

2240

Molar incisor enamel hypoplasia, with caries

9.77

45.72

5.8

2.5

1.14

1.66

e9/l

2.03

Acute generalized exanthematous pustulosis

129

6.28

45.43

2.9

2.6

1.17

1.29

e9/l

0.43

118

Pneumonia derived septicemia

101

7.14

45.24

2.4

2.9

1.33

1.21

e9/l

0.35

Acute lymphocytic leukaemia, including Hilmo

16.83

45.19

7.4

2.4

1.28

1.51

e9/l

0.40

Acute lymphocytic leukaemia, helper endpoint

16.83

45.19

7.4

2.4

1.28

1.51

e9/l

0.40

Acute lymphocytic leukaemia

16.83

45.19

7.4

2.4

1.28

1.51

e9/l

0.40

Exfoliative dermatitis

17.37

44.89

2.8

2.0

1.46

0.95

e9/l

0.61

Neurotic, stress-related and somatoform disorders

734

2889

1.79

44.62

2.7

2.4

1.35

1.20

e9/l

2.66

664

2562

FESS (DNB20)

153

445

3.51

43.99

2.2

2.5

1.33

1.21

e9/l

0.99

134

407

Ethmoidectomy

157

465

3.44

43.87

2.2

2.6

1.33

1.21

e9/l

1.15

138

424

Abdominal and pelvic pain

794

2260

1.77

43.67

2.7

2.4

1.20

1.18

e9/l

0.25

700

2005

Generalized skin eruption due to drugs and medicaments

118

6.44

43.54

2.8

2.7

1.21

1.30

e9/l

0.31

107

Other/unspecified rheumatoid arthritis

133

355

3.82

43.42

1.9

2.1

1.02

1.10

e9/l

0.50

120

323

Asthma and allergy

119

288

4.13

43.41

1.7

2.8

1.49

1.23

e9/l

2.56

238

Anxiety disorders, excluding more controls

678

2435

1.82

43.24

2.7

2.3

1.33

1.18

e9/l

2.31

613

2175

Asthma and allergy, excluding more controls

119

289

4.11

43.21

1.7

2.8

1.49

1.24

e9/l

2.32

239

Disturbances of skin sensation

263

1044

2.55

43.10

2.6

2.4

1.30

1.24

e9/l

0.57

226

928

All influenza (not pneumonia)

148

427

3.52

42.97

2.7

1.25

1.18

e9/l

0.44

131

364

L01XX Other antineoplastic agents

140

5.82

42.80

2.8

1.9

2.40

1.16

e9/l

0.48

128

Anxiety disorders

734

2919

1.76

42.50

2.7

2.4

1.35

1.20

e9/l

2.67

664

2589

Mycoses

687

3391

1.77

42.24

2.4

1.23

1.22

e9/l

0.11

605

3039

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

424

2009

2.07

42.23

2.0

2.5

1.31

1.09

e9/l

5.09

382

1809

Metabolic disorders

750

2612

1.76

42.21

2.3

2.5

1.23

1.16

e9/l

1.32

672

2325

Pleural effusion

146

424

3.50

42.00

2.3

2.1

0.98

1.11

e9/l

0.87

138

387

Viral infections of the central nervous system

107

250

4.39

41.99

2.7

2.3

1.36

1.30

e9/l

0.24

228

Viral infections of the central nervous system

102

230

4.55

41.89

2.8

2.2

1.35

1.30

e9/l

0.19

209

Codeine or tramadol medication

866

2807

1.70

41.67

2.3

2.4

1.27

1.20

e9/l

0.86

774

2525

Pain in joint

466

1467

2.04

41.16

2.2

2.3

1.31

1.14

e9/l

3.80

424

1302

Sicca syndrome [Sjögren]

103

238

4.43

40.98

2.4

2.2

1.01

1.12

e9/l

0.74

215

Other problems related to primary support group, including family circumstances

169

530

3.17

40.96

3.8

2.5

1.37

1.39

e9/l

0.08

140

452

Pain in throat and chest

631

2071

1.84

40.82

2.4

2.5

1.21

1.18

e9/l

0.34

556

1835

Pneumococcal septicemia

100

6.79

40.70

2.5

2.8

1.34

1.25

e9/l

0.20

Hypoplasia of dental enamel

100

7.73

40.63

5.4

3.1

1.02

1.52

e9/l

2.61

Malignant neoplasm of bronchus and lung, including Hilmo

130

289

3.80

40.46

1.8

1.9

0.94

1.07

e9/l

1.09

124

260

Convulsions, not elsewhere classified

184

624

2.94

39.80

2.8

2.4

1.30

1.26

e9/l

0.24

157

552

Basal cell carcinoma

236

611

2.69

39.80

2.1

2.0

1.09

1.26

e9/l

0.52

207

553

Viral pneumonia (unknown virus, not influenza)

228

4.46

39.62

2.5

2.4

1.04

1.25

e9/l

1.53

205

Other functional intestinal disorders

378

1674

2.11

39.61

2.5

1.26

1.19

e9/l

0.67

329

1483

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

112

284

4.03

39.40

2.5

2.3

1.25

1.18

e9/l

0.32

258

COPD (mode)

173

439

3.12

39.24

1.8

2.3

1.16

1.12

e9/l

0.19

156

402

Low back pain

598

2367

1.82

39.17

2.4

1.27

1.21

e9/l

0.57

534

2111

Chronic rhinitis, nasopharyngitis and pharyngitis

285

1227

2.35

39.09

1.9

2.6

1.38

1.12

e9/l

4.51

249

1086

Extracorporeal dialysis

199

4.72

38.91

2.6

2.5

1.07

1.21

e9/l

0.50

179

Heart failure,strict

385

1287

2.13

38.88

2.1

2.4

0.95

1.20

e9/l

2.57

351

1169

Cellulitis

219

838

2.65

38.81

2.6

2.5

1.18

1.21

e9/l

0.18

201

741

Other infectious diseases

220

4.47

38.62

2.8

2.3

1.09

1.19

e9/l

0.45

199

Budesonide

126

352

3.63

38.46

2.1

2.6

1.00

1.22

e9/l

2.22

109

322

Acute tubulo-interstitial nephritis

472

2119

1.93

38.34

2.4

1.23

1.24

e9/l

0.10

423

1883

Secondary hypertension

211

4.49

38.03

1.9

2.9

1.17

1.19

e9/l

0.06

182

Other diseases of pericardium

104

6.34

37.90

2.2

1.03

1.24

e9/l

0.66

9.62

37.70

1.4

2.3

1.64

1.13

e9/l

2.19

Disorders of mineral metabolism

103

254

4.15

37.65

2.3

2.4

1.09

1.14

e9/l

0.19

226

Other infectious diseases

106

267

4.05

37.63

2.7

2.3

1.11

1.20

e9/l

0.45

239

Malignant neoplasm of other connective and soft tissue, including Hilmo

7.68

37.48

2.0

1.9

0.78

1.32

e9/l

3.20

Vocal cord dysfunction

125

311

3.65

37.43

1.8

3.2

1.29

1.24

e9/l

0.29

108

289

Other viral diseases, not elsewhere classified

273

1172

2.34

37.27

2.9

2.7

1.40

1.29

e9/l

0.97

239

1000

Disorders of sclera, cornea, iris and ciliary body

444

2310

1.94

37.10

2.6

2.4

1.23

1.17

e9/l

0.75

409

2051

Noninfectious colitis NAS

148

470

3.20

36.98

2.7

2.6

1.31

1.22

e9/l

0.50

134

417

Nonsuppurative otitis media

243

854

2.49

36.91

2.7

2.5

1.33

1.29

e9/l

0.24

211

733

L01XE Protein kinase inhibitors

161

5.07

36.77

4.2

1.9

2.27

1.15

e9/l

0.45

145

Other viral diseases, not elsewhere classified

210

807

2.63

36.74

3.3

2.6

1.41

1.28

e9/l

0.89

187

693

Exclusions for E4_PCOS_BROAD

202

765

2.68

36.59

2.6

2.7

1.26

1.25

e9/l

0.05

176

665

Basal cell carcinoma, including avohilmo

239

648

2.56

36.51

2.1

1.07

1.26

e9/l

0.64

211

584

Other soft tissue disorders, not elsewhere classified

743

2584

1.69

36.23

2.4

2.5

1.30

1.23

e9/l

0.77

660

2277

Biological medication for rheuma

194

725

2.72

36.13

1.8

2.7

1.27

1.26

e9/l

0.08

169

641

143

452

3.21

36.01

2.3

2.6

1.20

1.22

e9/l

0.05

128

395

Other (seronegative) rheumatoid arthritis, wide

177

632

2.84

35.93

1.9

2.3

1.04

1.18

e9/l

1.16

159

569

Other diseases of upper respiratory tract

818

2585

1.66

35.78

2.5

1.34

1.16

e9/l

3.26

727

2301

Hypertensive diseases (excluding secondary)

425

1233

2.02

35.69

2.0

2.8

1.27

1.25

e9/l

0.17

379

1085

Diseases of the musculoskeletal system and connective tissue

459

1166

1.98

35.61

2.6

2.5

1.32

1.26

e9/l

0.69

392

992

Molar incisor enamel hypoplasia

211

4.42

35.26

4.5

2.9

1.13

1.55

e9/l

3.13

165

5-aminosalicylic acid

169

595

2.87

35.15

2.0

2.9

1.18

1.23

e9/l

0.28

150

532

Postprocedural disorders of nervous system

100

255

4.02

34.99

2.4

2.5

1.25

1.34

e9/l

0.48

226

Complications of procedures, not elsewhere classified

597

2839

1.75

34.99

2.1

2.3

1.22

1.21

e9/l

0.07

539

2538

Other complications of surgical and medical care, not elsewhere classified

114

319

3.64

34.85

2.3

2.4

1.19

1.21

e9/l

0.06

288

Other specific joint derangements/joint disorders

581

2117

1.78

34.67

2.3

2.5

1.31

1.19

e9/l

2.29

527

1870

Dysphagia

200

775

2.61

34.55

2.2

2.3

1.23

1.14

e9/l

0.68

174

701

Malignant neoplasm, without specification of site, including Hilmo

7.99

34.52

2.8

2.5

1.08

1.21

e9/l

0.42

Osteonecrosis

170

4.77

34.44

2.6

2.0

1.11

1.22

e9/l

0.49

154

Other disorders of urethra and urinary system

530

2118

1.82

34.38

2.4

2.3

1.25

1.16

e9/l

1.49

471

1905

Conjunctivitis (acute, non atopic)

273

1217

2.26

34.30

2.4

2.6

1.23

1.27

e9/l

0.39

250

1048

Recurrent aphthous stomatitis , including avohilmo

155

529

2.98

34.25

3.4

2.4

1.17

1.23

e9/l

0.42

134

465

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

354

1068

2.11

34.14

2.5

2.8

1.17

1.21

e9/l

0.47

315

952

Stomatitis and related lesions

201

790

2.58

33.83

3.3

2.4

1.15

1.22

e9/l

0.67

172

691

Other and unspecified polyneuropathies, also in other diseases

172

626

2.78

33.71

3.0

2.3

1.31

1.08

e9/l

2.45

154

568

Viral warts

118

346

3.48

33.63

2.5

2.6

1.22

1.28

e9/l

0.31

106

305

Presence of other functional implants

401

1413

1.98

33.52

2.0

2.1

1.12

1.19

e9/l

0.40

375

1279

Disorders of calcium metabolism

186

4.52

33.49

2.3

1.09

1.11

e9/l

0.06

167

Other symptoms and signs involving the digestive system and abdomen

152

524

2.94

32.93

3.0

2.5

1.25

1.23

e9/l

0.11

140

473

Glomerular disorders in diseases classified elsewhere

124

381

3.31

32.80

2.0

2.6

1.01

1.13

e9/l

0.85

114

342

Abnormal findings on diagnostic imaging of other body structures

128

401

3.24

32.76

2.7

2.2

1.04

1.24

e9/l

1.81

116

358

Neuromuscular dysfunction of bladder

103

281

3.74

32.72

3.1

2.3

1.32

1.14

e9/l

1.12

251

Lung diseases due to external agents

128

405

3.20

32.21

2.0

2.2

0.99

1.14

e9/l

1.15

119

366

Other and unspecified drugs and medicaments

100

271

3.77

32.11

2.5

1.27

1.24

e9/l

0.09

246

Non-small cell lung cancer, including Hilmo

218

4.01

32.09

1.7

1.8

0.86

1.07

e9/l

1.98

197

Bleeding

611

2563

1.70

31.81

2.4

2.5

1.28

1.17

e9/l

0.30

546

2298

Acute suppurative otitis media

264

1118

2.23

31.69

2.8

2.6

1.38

1.31

e9/l

0.60

234

969

Diseases of the ear and mastoid process

877

2800

1.58

31.48

2.2

2.5

1.24

1.23

e9/l

0.14

777

2491

Etanercept

228

4.00

31.01

1.6

2.8

1.34

1.29

e9/l

0.15

203

Disorders of lens

485

1672

1.82

30.84

2.4

1.17

1.12

e9/l

0.43

444

1522

Antihypertensive medication - note that there are other indications

528

1571

1.79

30.65

2.3

2.7

1.34

1.31

e9/l

0.13

466

1369

Episodal and paroxysmal disorders

839

2707

1.58

30.64

2.4

2.5

1.30

1.19

e9/l

2.80

752

2381

Diseases of middle ear and mastoid

476

2182

1.80

30.48

2.4

2.5

1.27

1.25

e9/l

0.15

426

1914

Tumor necrosis factor alpha inhibitors

169

644

2.66

30.38

1.8

2.6

1.26

1.27

e9/l

0.02

147

568

Persons encountering health services in other circumstances

310

1520

2.04

30.35

2.3

2.5

1.29

1.21

e9/l

0.82

293

1329

Other disorders of optic [2nd] nerve and visual pathways

211

4.08

30.08

3.6

2.4

1.41

1.32

e9/l

0.31

182

Dermatopolymyositis

10.03

30.02

2.1

2.0

1.06

1.09

e9/l

0.07

Obesity related asthma

274

1296

2.13

30.02

1.9

2.6

1.42

1.16

e9/l

4.23

246

1166

Dorsalgia

743

2473

1.62

29.85

2.4

1.30

1.21

e9/l

1.10

667

2200

Cutaneous abscess, furuncle and carbuncle

233

1038

2.27

29.69

2.2

2.6

1.23

1.24

e9/l

0.05

200

918

Hypoplasia of dental enamel , including avohilmo

203

4.17

29.63

4.9

2.9

1.07

1.55

e9/l

4.08

159

Cerebrovascular diseases (FINNGEN)

239

740

2.30

29.44

2.3

2.9

1.24

1.19

e9/l

0.30

211

668

Heart failure and antihypertensive medication

211

566

2.46

29.42

2.4

2.6

0.93

1.23

e9/l

1.06

190

513

Pain (limb, back, neck, head abdominally)

548

1571

1.76

29.40

2.8

2.4

1.28

1.15

e9/l

2.29

479

1387

Hypothyroidism, strict autoimmune

434

1553

1.85

29.27

2.3

1.18

1.26

e9/l

0.58

389

1378

Lower back pain or/and sciatica

767

3184

1.58

29.25

2.4

2.3

1.28

1.20

e9/l

1.21

692

2851

Other and unspecified tonsillitis

267

1049

2.15

29.17

2.6

2.5

1.34

1.29

e9/l

0.42

245

918

Disorders of thyroid, IBD co-morbidities

120

257

3.31

29.05

2.3

2.0

1.21

1.18

e9/l

0.12

107

223

Disorders of oesophagus in diseases classified elsewhere

8.78

28.95

1.5

2.0

1.40

1.19

e9/l

0.48

Iridocyclitis

202

856

2.39

28.95

2.2

2.5

1.24

1.19

e9/l

0.34

187

757

COPD, hospital admissions 3, with asthma pneumonia sepsis

205

736

2.40

28.93

1.7

2.2

1.24

1.08

e9/l

1.60

186

671

Localized swelling, mass and lump of skin and subcutaneous tissue

256

1199

2.15

28.81

2.8

2.4

1.13

1.19

e9/l

0.59

229

1073

Urticaria

270

1292

2.11

28.75

2.4

2.7

1.38

1.27

e9/l

1.15

228

1126

Suppurative and unspecified otitis media

320

1435

1.99

28.57

2.7

2.5

1.35

1.27

e9/l

0.92

286

1244

Chronic iridocyclitis

132

4.89

28.40

2.1

2.3

1.27

1.26

e9/l

0.02

123

Unspecified kidney failure

253

3.65

28.13

2.5

2.2

1.09

1.10

e9/l

0.02

224

Pain in limb

614

2502

1.65

28.05

2.5

1.29

1.23

e9/l

0.58

541

2209

Heart failure, strict

393

1490

1.87

28.03

2.1

2.4

0.95

1.19

e9/l

2.85

359

1351

Childhood asthma (age<16)

109

258

3.36

28.00

2.1

2.8

1.36

1.29

e9/l

0.34

204

Childhood asthma (age<16), excluding more controls

109

258

3.36

27.98

2.1

2.8

1.36

1.30

e9/l

0.31

204

Use of hypnotics and sedatives

777

2862

1.56

27.77

2.4

1.21

e9/l

0.02

683

2570

Seronegative rheumatoid arthritis

103

314

3.33

27.62

2.0

2.5

1.09

1.23

e9/l

0.66

288

All-cause Heart Failure

385

1462

1.87

27.42

2.1

2.4

0.94

1.19

e9/l

2.85

352

1328

Subjective visual disturbances

210

927

2.29

27.40

2.5

1.32

1.19

e9/l

1.10

190

819

Disorders of conjunctiva

627

3137

1.61

27.03

2.3

2.5

1.26

1.24

e9/l

0.18

557

2776

Continuous positive airway pressure

157

505

2.64

27.03

2.4

2.8

1.44

1.21

e9/l

1.56

141

440

Systemic sclerosis (FG)

7.50

26.88

1.9

2.5

1.15

1.11

e9/l

0.07

Nerve, nerve root and plexus disorders

752

2968

1.56

26.75

2.3

2.4

1.22

1.20

e9/l

0.09

678

2659

Migraine

390

1737

1.83

26.73

2.3

2.5

1.58

1.22

e9/l

0.82

348

1524

Other diseases of urinary system

743

2683

1.56

26.33

2.8

2.4

1.24

1.17

e9/l

1.24

656

2406

Disorders of ocular muscles, binocular movement, accommodation and refraction

386

2128

1.81

26.32

3.0

2.5

1.32

1.24

e9/l

1.01

341

1861

Other pleural conditions

251

3.56

26.21

2.3

2.1

0.84

1.15

e9/l

3.08

225

Diseases of the digestive system

336

1784

1.89

26.18

2.4

2.5

1.13

1.17

e9/l

0.46

311

1582

Special screening examination for infectious and parasitic diseases

169

493

2.54

26.13

2.1

1.50

1.19

e9/l

4.72

147

428

Hypercalcemia

118

4.97

26.12

2.5

2.1

1.04

1.19

e9/l

0.48

107

Systemic sclerosis

7.23

26.03

1.9

2.3

1.15

1.10

e9/l

0.11

Epilepsy

257

1250

2.07

26.01

2.4

2.7

1.56

1.21

e9/l

0.43

225

1093

Carrier of infectious disease

6.36

26.00

2.2

2.3

3.57

1.24

e9/l

0.51

Eosinophilia

8.90

25.99

1.7

1.9

1.13

1.10

e9/l

0.06

Covid-19 suspected case

196

863

2.29

25.77

2.2

2.6

1.18

1.26

e9/l

0.64

165

763

Mood disorders, excluding more controls

676

2558

1.58

25.72

2.6

2.3

1.30

1.17

e9/l

1.84

603

2292

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

105

338

3.13

25.72

1.7

2.1

0.92

1.11

e9/l

2.08

309

Later onset COPD, excluding more controls

105

251

3.26

25.61

1.8

2.1

1.08

1.03

e9/l

0.24

231

Viral warts

188

816

2.33

25.57

2.6

2.5

1.20

1.25

e9/l

0.33

171

717

Other diseases of lip and oral mucosa

307

1609

1.92

25.35

2.3

2.5

1.20

1.19

e9/l

0.05

280

1435

Iron deficiency anaemia secondary to blood loss (chronic)

133

493

2.73

25.29

1.8

2.3

0.95

1.12

e9/l

1.86

123

438

COPD, hospital admission 2, with asthma infections

225

897

2.17

25.10

1.7

2.2

1.24

1.09

e9/l

1.62

202

815

Other abnormal findings of blood chemistry

134

4.60

25.09

2.5

2.1

1.03

1.23

e9/l

0.89

125

Inflammatory bowel disease

266

1333

2.01

25.05

2.2

2.6

1.15

1.22

e9/l

0.68

240

1169

Non-ischemic cardiomyopathy

224

834

2.18

25.02

2.4

1.01

1.14

e9/l

1.50

203

751

Other neurological diseases

499

2355

1.67

24.90

2.4

1.15

1.18

e9/l

0.20

451

2112

Persons with potential health hazards related to communicable diseases

335

1801

1.86

24.84

2.7

2.5

1.66

1.30

e9/l

0.63

289

1556

Glomerulonephritis

108

362

3.04

24.82

2.1

2.6

1.27

1.19

e9/l

0.29

101

318

Abnormality of white blood cells, not elsewhere classified

10.21

24.79

4.5

1.9

1.12

1.23

e9/l

0.17

Polyuria

181

784

2.33

24.75

3.1

2.3

1.37

1.10

e9/l

2.62

166

711

Arthropathies

683

2212

1.57

24.23

2.4

2.6

1.29

1.20

e9/l

1.67

608

1941

Hypokalaemia

105

351

3.03

24.20

1.8

2.4

1.28

1.11

e9/l

1.05

314

Collagenous colitis

285

3.28

24.15

2.2

2.4

1.35

1.18

e9/l

0.83

260

Lack of expected normal physiological development

5.78

24.04

4.5

2.0

1.60

1.72

e9/l

0.22

Acute pharyngitis

135

513

2.64

24.02

2.5

2.6

1.33

1.26

e9/l

0.36

116

436

Hypertension, essential

555

1927

1.64

23.94

2.1

2.6

1.20

1.23

e9/l

0.18

501

1716

Acute lymphadenitis

192

3.83

23.78

3.1

2.8

1.16

1.29

e9/l

0.61

172

Viral meningitis

108

4.95

23.76

3.0

2.3

1.36

1.24

e9/l

0.45

101

Systemic sclerosis, icd10

6.53

23.70

1.9

2.1

1.15

1.14

e9/l

0.01

Disorders of parathyroid gland

151

607

2.48

23.68

2.1

2.3

1.07

1.15

e9/l

0.57

144

544

Meningitis

141

4.35

23.52

1.9

2.3

1.35

1.29

e9/l

0.16

125

Anterior Iridocyclitis

174

759

2.32

23.46

2.2

2.5

1.22

1.21

e9/l

0.05

163

674

Constipation

635

2828

1.56

23.39

2.2

2.5

1.15

1.22

e9/l

0.75

551

2532

Depression

692

3076

1.53

23.27

2.6

2.4

1.31

1.19

e9/l

1.82

614

2753

Diplopia

118

430

2.78

23.26

2.7

2.4

1.25

1.16

e9/l

0.70

107

390

Atrial fibrillation and flutter

221

668

2.16

23.08

2.4

2.9

1.05

1.15

e9/l

0.86

200

604

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

252

1261

1.99

23.05

3.4

2.4

1.42

1.33

e9/l

0.60

206

1092

Mood disorders

734

3156

1.51

23.03

2.5

2.4

1.32

1.19

e9/l

2.22

652

2827

Conjunctivitis

562

2970

1.59

23.00

2.4

2.5

1.27

1.25

e9/l

0.18

497

2621

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

169

3.95

22.99

2.4

1.8

1.02

1.13

e9/l

0.50

155

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

404

2369

1.71

22.88

2.2

2.4

1.21

1.15

e9/l

0.65

366

2120

Otitis media, unspecified

124

427

2.71

22.86

3.0

2.5

1.46

1.34

e9/l

0.61

109

358

Hypo-osmolality and hyponatraemia

136

534

2.56

22.80

2.3

2.5

1.83

1.10

e9/l

0.52

124

483

Hypertension

576

2039

1.60

22.74

2.1

2.6

1.23

1.25

e9/l

0.10

513

1802

Hypertensive diseases

577

2046

1.60

22.64

2.1

2.6

1.23

1.25

e9/l

0.10

514

1808

Ulcerative colitis, NAS

136

541

2.55

22.53

2.1

2.5

1.21

1.18

e9/l

0.13

122

478

Mood [affective] disorders

730

3156

1.50

22.52

2.5

2.4

1.32

1.19

e9/l

2.25

648

2827

Chronic ulcer of skin, not elsewhere classified

188

3.74

22.09

2.0

1.06

1.11

e9/l

0.20

170

Endocrine, nutritional and metabolic diseases

614

1983

1.57

22.07

2.5

2.6

1.32

1.20

e9/l

2.18

533

1731

Viral and other specified intestinal infections

191

870

2.16

21.77

2.7

1.31

1.29

e9/l

0.15

172

754

Malignant neoplasm of digestive organs

173

602

2.28

21.63

2.0

2.1

1.11

1.26

e9/l

0.37

159

546

Adalimumab

103

364

2.88

21.58

2.0

2.7

1.25

1.28

e9/l

0.09

327

Benign neoplasms

711

2608

1.51

21.52

2.3

2.5

1.19

1.21

e9/l

0.21

626

2324

Myalgia

189

884

2.16

21.51

2.0

2.5

1.40

1.20

e9/l

2.31

172

787

Suppurative and necrotic conditions of lower respiratory tract

156

3.99

21.40

1.7

2.4

1.05

1.15

e9/l

0.35

140

Dental operations

406

1207

1.73

21.29

2.5

2.1

1.19

e9/l

0.02

366

1053

Diseases of liver

259

1362

1.92

21.28

2.2

2.5

1.18

e9/l

0.00

230

1225

Valvular heart disease excluding rheumatic fever

325

1302

1.81

21.24

2.3

2.6

1.03

1.25

e9/l

1.68

293

1179

248

1175

1.95

21.12

2.1

1.07

1.16

e9/l

0.44

222

1074

Functional dyspepsia

197

945

2.10

21.00

2.1

2.4

1.26

1.17

e9/l

0.88

172

849

Soft tissue disorders

753

2625

1.48

20.69

2.5

1.31

1.23

e9/l

0.90

673

2310

Crohn disease

126

504

2.53

20.68

2.3

2.5

1.07

1.21

e9/l

1.04

116

440

Papulosquamous disorders

282

1541

1.84

20.56

2.1

2.5

1.17

1.18

e9/l

0.06

255

1389

Malignant neoplasm of urinary organs

156

3.89

20.50

1.8

1.9

1.02

1.12

e9/l

0.46

144

Acute and subacute iridocyclitis

159

708

2.27

20.49

2.2

2.5

1.22

1.19

e9/l

0.11

150

627

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

654

2787

1.51

20.44

2.3

2.4

1.11

1.19

e9/l

1.49

584

2507

Senile cataract

401

1451

1.70

20.43

2.3

2.4

1.13

1.10

e9/l

0.30

369

1327

Malignant neoplasm of kidney, except renal pelvis

144

4.00

20.27

1.8

1.02

1.13

e9/l

0.46

132

Rash and other nonspecific skin eruption

322

2.93

20.24

3.0

2.3

1.24

1.21

e9/l

0.15

290

Myeloproliferative diseases

229

3.33

20.22

3.8

2.0

2.29

1.17

e9/l

0.41

208

Diseases of the myoneural junction and muscle

106

394

2.73

20.19

2.6

2.5

1.15

1.13

e9/l

0.11

355

Irritable bowel syndrome

206

1020

2.03

20.18

2.2

2.5

1.36

1.20

e9/l

1.94

183

905

Diseases of oral cavity, salivary glands and jaws

387

1155

1.73

20.16

2.4

2.2

1.22

1.26

e9/l

0.15

343

1031

Simple and mucopurulent chronic bronchitis

111

4.51

20.16

1.9

2.6

1.69

1.11

e9/l

2.52

Spondylopathies

524

1984

1.58

20.13

2.1

2.4

1.21

1.18

e9/l

0.25

470

1782

Malignant neoplasm, without specification of site

8.09

20.07

2.9

1.6

1.05

1.23

e9/l

0.35

Hypothyroidism, drug reimbursement

199

3.14

19.89

2.3

1.07

1.25

e9/l

1.42

174

Diseases of arteries, arterioles and capillaries (FINNGEN)

167

515

2.26

19.84

2.0

2.9

1.05

1.14

e9/l

0.74

148

471

Chronic diseases of tonsils and adenoids

557

2278

1.55

19.79

2.6

1.38

1.19

e9/l

2.75

498

2024

Vasomotor and allergic rhinitis

279

1508

1.83

19.78

2.0

2.6

1.36

1.17

e9/l

3.76

248

1322

Other and unspecified urticaria

174

816

2.15

19.75

2.2

2.7

1.40

1.25

e9/l

1.34

152

714

Disorders of skin appendages

357

2111

1.70

19.73

2.3

2.5

1.29

1.21

e9/l

0.79

315

1875

Other antidepressants

718

2492

1.48

19.67

2.3

2.4

1.26

1.18

e9/l

0.89

630

2252

Symptoms and signs involving speech and voice

239

1258

1.91

19.63

1.9

2.4

1.20

1.19

e9/l

0.08

211

1129

Skin changes due to chronic exposure to nonionizing radiation

230

1098

1.94

19.56

2.1

1.04

1.17

e9/l

0.61

207

1002

Other dorsopathies, not elsewhere classified

704

2493

1.48

19.51

2.3

2.4

1.30

1.21

e9/l

1.11

628

2218

Other CVD (FINNGEN)

217

3.10

19.50

1.6

2.7

1.21

1.07

e9/l

0.62

198

COPD

277

1238

1.84

19.50

1.7

2.4

1.18

1.08

e9/l

1.07

249

1133

Non-rheumatic valve diseases

314

1278

1.78

19.47

2.3

2.6

1.04

1.24

e9/l

1.47

285

1159

Cardiac arrhythmias

444

1779

1.63

19.46

2.3

2.7

1.20

1.23

e9/l

0.28

391

1572

Genitourinary diseases

446

1362

1.65

19.38

3.1

2.4

1.27

1.20

e9/l

0.72

391

1185

Intracranial trauma

361

1491

1.71

19.30

2.3

1.26

1.17

e9/l

1.09

317

1306

Ocular pain

273

3.05

19.16

3.0

2.7

1.37

1.25

e9/l

0.66

239

Actinic keratosis

223

1070

1.94

18.93

2.1

2.0

0.98

1.16

e9/l

1.19

200

975

Viral and other specified intestinal infections

229

1159

1.92

18.90

2.6

2.7

1.34

1.29

e9/l

0.30

205

1005

Volume depletion

255

3.10

18.78

1.9

2.5

1.01

1.14

e9/l

0.73

228

Congenital malformations, deformations and chromosomal abnormalities

439

2637

1.59

18.72

2.4

2.5

1.28

1.25

e9/l

0.41

387

2326

Chronic apical periodontitis

766

3038

1.44

18.66

2.4

2.3

1.18

1.23

e9/l

0.57

694

2704

Somatoform disorder

133

574

2.34

18.50

2.0

2.6

1.46

1.21

e9/l

1.86

116

515

Other joint disorders

620

2181

1.50

18.49

2.3

2.5

1.32

1.20

e9/l

2.73

560

1921

Erythema multiforme

5.97

18.48

2.2

2.5

1.20

1.33

e9/l

0.27

Any mental disorder

766

2666

1.44

18.36

2.7

2.3

1.27

1.18

e9/l

0.99

671

2374

Temporomandibular joint disorders, including avohilmo

322

1865

1.71

18.31

2.0

2.4

1.38

1.23

e9/l

2.24

292

1648

Follow-up examination after treatment for conditions other than malignant neoplasms

239

831

1.91

18.24

2.7

2.1

1.36

1.12

e9/l

2.84

209

746

Spondyloarthritis

123

516

2.40

18.21

1.6

2.2

1.20

1.25

e9/l

0.23

106

452

Other and unspecified diseases of blood and blood-forming organs

5.98

17.99

2.1

2.0

1.47

1.21

e9/l

0.53

All anxiety disorders

438

2192

1.59

17.87

2.5

1.42

1.20

e9/l

6.66

390

1938

Fentanyl

231

3.14

17.84

2.4

2.3

1.13

1.05

e9/l

0.32

207

Drug-induced polyneuropathy

7.57

17.65

6.0

3.3

1.13

1.14

e9/l

0.01

Other disorders of ear

631

2819

1.47

17.62

2.4

2.5

1.19

1.20

e9/l

0.07

578

2498

Gastric ulcer

120

506

2.39

17.59

1.9

2.3

0.94

1.06

e9/l

0.85

107

462

Other metabolic disorders

116

484

2.42

17.46

3.3

2.5

1.23

1.22

e9/l

0.07

100

427

Other chronic obstructive pulmonary disease

260

1191

1.81

17.44

1.7

2.4

1.21

1.08

e9/l

1.55

234

1088

Postprocedural endocrine and metabolic disorders, not elsewhere classified

107

432

2.51

17.30

3.0

2.4

1.25

1.21

e9/l

0.15

384

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

198

1019

1.95

17.23

2.2

2.4

1.39

1.23

e9/l

2.03

164

903

Other general symptoms and signs

124

3.98

17.20

2.0

1.40

1.38

e9/l

0.05

109

Misadventures to patients during surgical and medical care

112

464

2.44

17.12

2.3

2.2

1.11

1.12

e9/l

0.08

101

417

Acute bronchiolitis

300

2.76

17.06

3.2

1.32

1.37

e9/l

0.18

228

Viral hepatitis, IBD co-morbidity

4.46

16.83

3.4

2.4

1.47

1.14

e9/l

1.00

Dorsopathies

716

2543

1.44

16.80

2.4

1.30

1.21

e9/l

1.06

634

2252

Diaphragmatic hernia

231

1266

1.84

16.80

2.3

1.17

1.14

e9/l

0.17

213

1155

Seropositive rheumatoid arthritis, strict definition

117

499

2.37

16.78

2.3

2.4

0.96

1.21

e9/l

2.82

103

450

Malignant neoplasm of endocrine gland

146

3.68

16.76

2.9

2.3

1.17

1.19

e9/l

0.08

131

Congenital malformations, deformations and chromosomal abnormalities

464

2800

1.53

16.75

2.4

2.5

1.28

1.23

e9/l

0.66

408

2478

Abnormal weight loss

306

2.79

16.73

2.4

1.33

1.20

e9/l

0.49

270

Other disorders of eye and adnexa

121

526

2.33

16.62

2.8

2.3

1.41

1.24

e9/l

1.09

107

455

Sequelae of external causes of morbidity and mortality

188

970

1.95

16.51

2.7

2.3

1.29

1.17

e9/l

0.85

166

868

Rheumatism, unspecified

104

424

2.48

16.48

1.6

2.3

1.41

1.13

e9/l

2.93

384

Abnormalities of heart beat

218

1156

1.86

16.47

2.0

2.5

1.20

1.15

e9/l

0.39

195

1030

Atopic dermatitis, strict definition with reimbursement

235

1257

1.82

16.42

2.6

1.33

1.30

e9/l

0.19

204

1080

Other cataract

277

1204

1.75

16.41

2.5

2.3

1.15

1.10

e9/l

0.51

248

1091

Dentofacial anomalies [including malocclusion]

493

2628

1.51

16.38

2.3

2.5

1.32

1.22

e9/l

1.48

445

2316

Chronic gastritis

171

856

2.01

16.35

2.4

2.2

1.22

1.12

e9/l

0.76

156

777

Weight loss

340

2.65

16.18

2.7

2.5

1.34

1.20

e9/l

0.59

301

Other symptoms and signs involving the circulatory and respiratory systems

184

3.31

16.13

2.0

2.7

1.11

1.14

e9/l

0.13

162

Retention of urine

218

967

1.86

16.05

2.2

2.3

1.16

1.07

e9/l

0.85

191

891

Other gastritis (incl. Duodenitis)

152

735

2.08

16.01

2.2

2.4

1.14

1.13

e9/l

0.06

141

666

Chronic laryngitis and laryngotracheitis

106

442

2.42

16.01

1.7

2.5

1.34

1.11

e9/l

2.54

404

Other specified and unspecified retinal disorders

4.40

16.00

2.8

2.1

1.06

1.29

e9/l

0.87

Hypopituitarism

297

2.77

15.98

2.7

2.9

1.29

1.25

e9/l

0.14

257

Raynaud syndrome

292

2.78

15.90

1.6

2.4

0.98

1.29

e9/l

2.74

265

IBD patients in KELA-register

181

935

1.95

15.86

1.9

2.6

1.13

1.24

e9/l

0.96

165

814

Biological medicines for asthma

5.64

15.83

1.2

2.4

1.63

1.27

e9/l

1.02

Concussion

302

1471

1.68

15.77

2.4

2.3

1.29

1.17

e9/l

1.43

266

1287

Ulcerative colitis

186

972

1.93

15.75

1.9

2.6

1.22

1.21

e9/l

0.09

165

855

Disorders of gallbladder, biliary tract and pancreas

646

2851

1.43

15.73

2.4

1.17

1.21

e9/l

0.37

578

2567

Sequelae with surgical and medical care as external cause

150

728

2.08

15.68

2.8

2.4

1.23

1.15

e9/l

0.49

135

657

Polyarthrosis

127

534

2.22

15.60

2.0

2.3

1.16

1.11

e9/l

0.25

118

482

Voice disturbances

191

1011

1.90

15.57

1.9

2.4

1.21

1.20

e9/l

0.06

168

903

Paralytic ileus and intestinal obstruction

167

845

1.99

15.50

2.1

2.4

1.09

1.14

e9/l

0.34

155

762

Exposure to unspecified factor

687

3525

1.41

15.43

2.2

2.5

1.26

1.22

e9/l

0.34

602

3143

Other headache syndromes

279

1654

1.69

15.42

2.3

2.5

1.43

1.17

e9/l

4.76

245

1461

Keratitis

249

1434

1.75

15.37

2.8

2.5

1.25

1.21

e9/l

0.31

228

1272

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

171

3.36

15.27

2.8

3.0

1.51

1.43

e9/l

0.21

135

Gastroduodenal ulcer

156

773

2.02

15.26

1.8

2.3

0.96

1.10

e9/l

1.30

139

704

Other/unspecified dorsalgia

249

1425

1.74

15.21

2.5

2.4

1.32

1.15

e9/l

1.50

227

1274

Fitting and adjustment of other devices

195

940

1.88

15.17

2.4

1.16

1.13

e9/l

0.19

189

852

Disorders of choroid and retina

509

2448

1.48

15.13

2.2

2.5

1.11

1.18

e9/l

0.77

462

2206

Other intervertebral disc disorders

533

2180

1.48

15.07

2.3

2.4

1.28

1.19

e9/l

0.81

481

1952

Suggestive for eosinophilic asthma

295

2.71

15.05

1.9

2.6

1.38

1.14

e9/l

1.43

269

Osteomyelitis

193

3.16

14.97

1.8

2.2

1.14

1.17

e9/l

0.06

174

Hypermobility syndrome

158

3.41

14.95

1.9

2.8

1.61

1.30

e9/l

1.10

142

Tonsillectomy and adenotomy

434

1989

1.52

14.71

2.6

1.48

1.27

e9/l

5.23

384

1718

Other ulcerative colitis

180

3.22

14.67

1.7

2.5

1.30

e9/l

0.01

164

Other embolism and thrombosis

411

2.41

14.66

2.2

2.4

1.02

1.14

e9/l

0.85

373

Speech and linguistic disorders, excluding more controls

308

2.60

14.52

3.8

2.6

1.48

1.35

e9/l

0.37

248

Missing teeth due to accident, extraction or parodontitis

368

2234

1.56

14.44

2.7

2.3

1.20

1.17

e9/l

0.22

333

2033

Congenital malformations of the respiratory system

4.19

14.41

2.6

3.5

1.54

1.39

e9/l

0.28

Other disorders of bone

148

739

2.02

14.36

2.7

2.6

1.40

1.21

e9/l

1.87

134

653

Benzodiazepine use

664

3281

1.40

14.30

2.5

2.4

1.29

1.20

e9/l

1.26

596

2936

Other endocrine disorders

279

2.70

14.27

4.4

2.9

1.52

1.43

e9/l

0.24

218

Anxiety (asthma-related co-morbidities)

425

2178

1.51

14.26

2.6

2.4

1.42

1.19

e9/l

6.59

380

1945

Other arrhythmias

409

2026

1.53

14.24

2.2

2.6

1.13

1.25

e9/l

1.15

364

1813

Pyothorax

120

3.74

14.21

1.7

2.1

1.01

1.19

e9/l

0.64

110

Fibromyalgia

305

2.62

14.11

1.7

2.5

1.45

1.24

e9/l

1.39

272

Ulcerative enterocolitis

4.42

14.10

1.9

2.3

1.30

1.18

e9/l

0.23

Other obstetric conditions, not elsewhere classified

236

854

1.77

14.07

2.1

2.5

1.42

1.37

e9/l

0.39

206

750

Acute laryngitis and tracheitis

412

2.36

14.02

3.0

2.5

1.33

1.35

e9/l

0.08

346

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

336

2.53

14.00

2.6

3.0

1.50

1.42

e9/l

0.33

272

Inflammatory bowel disease, strict (require KELA)

181

976

1.87

13.99

1.9

2.6

1.13

1.25

e9/l

1.09

165

852

Diseases of arteries, arterioles and capillaries

404

1961

1.53

13.98

2.0

2.4

1.08

1.18

e9/l

0.75

359

1790

Intestinal stricture

200

1114

1.81

13.90

2.1

2.4

1.06

1.16

e9/l

1.13

187

997

Migraine without aura

154

789

1.97

13.89

2.3

2.6

1.41

1.22

e9/l

1.81

131

681

Cerebral palsy and other paralytic syndromes

404

2.38

13.82

2.7

2.6

1.37

1.25

e9/l

0.51

357

Fissure and fistula of anal and rectal regions

166

874

1.91

13.81

2.3

2.4

1.18

1.20

e9/l

0.07

144

781

Dermatophytosis

429

2.33

13.79

2.3

2.4

1.10

1.17

e9/l

0.40

382

Hard cardiovascular diseases

552

2292

1.44

13.78

2.1

2.6

1.14

1.18

e9/l

0.50

503

2039

Congenital malformations of the respiratory system

4.20

13.70

2.6

3.6

1.59

1.41

e9/l

0.34

Morphin

6.62

13.70

1.5

1.8

1.07

1.15

e9/l

0.14

Diseases of salivary glands

218

1251

1.75

13.70

2.4

1.29

1.20

e9/l

0.64

189

1118

Varicella [chickenpox]

178

3.15

13.64

2.4

2.8

1.23

1.24

e9/l

0.02

156

Recurrent or chronic depression

281

1198

1.66

13.57

2.6

2.4

1.39

1.14

e9/l

4.77

245

1070

Atopic dermatitis

396

2146

1.52

13.55

2.5

1.38

1.24

e9/l

2.07

344

1881

L04AC Interleukin inhibitors

200

3.00

13.50

1.7

2.8

1.51

1.29

e9/l

0.61

183

Hypersensitivity pneumonitis due to organic dust

6.26

13.48

2.0

2.1

1.03

1.07

e9/l

0.06

Chronic hepatitis, not elsewhere classified

4.06

13.41

1.4

1.9

1.27

e9/l

0.01

Pyogenic arthritis

185

3.07

13.38

1.9

2.5

1.02

1.12

e9/l

0.38

168

Other or unspecified ileus, impaction or obstruction

118

556

2.14

13.38

1.9

2.3

1.09

1.16

e9/l

0.37

110

504

Endocarditis

4.52

13.34

1.9

3.0

0.94

1.28

e9/l

0.98

Symptoms and signs involving cognition, perception, emotional state and behaviour

636

3128

1.39

13.31

2.3

2.4

1.29

1.20

e9/l

1.20

570

2796

Diverticular disease of intestine

416

1766

1.51

13.30

2.1

2.4

1.18

1.12

e9/l

0.56

382

1604

GI-bleeding

195

1093

1.79

13.28

2.3

2.4

1.09

1.12

e9/l

0.19

177

976

Heart failure and bmi 25plus

214

816

1.78

13.27

2.3

2.4

0.94

1.16

e9/l

4.15

192

755

Other anxiety disorders

316

1736

1.58

13.22

2.4

2.5

1.46

1.22

e9/l

5.40

279

1528

Early onset COPD

151

783

1.94

13.19

1.7

2.5

1.30

1.14

e9/l

1.26

132

710

Gout, idiopatic and unspecified

151

783

1.94

13.18

2.5

2.2

1.03

1.07

e9/l

0.24

136

719

Complications of internal orthopaedic prosthetic devices, implants and grafts

138

694

2.00

13.16

1.9

2.1

1.16

1.11

e9/l

0.20

120

632

Deforming dorsopathies

191

1068

1.80

13.14

2.0

2.5

1.17

1.19

e9/l

0.12

174

963

Other diseases of blood and blood-forming organs

182

3.06

13.11

1.9

2.1

1.35

1.20

e9/l

0.41

167

Disorders of refraction and accommodation

211

1211

1.75

13.11

3.2

2.6

1.39

1.27

e9/l

0.93

181

1038

Other diseases of hard tissues of teeth

350

1151

1.58

13.10

2.5

2.2

1.21

1.25

e9/l

0.16

302

1027

Faecal incontinence

214

2.88

13.10

2.5

2.1

1.07

1.12

e9/l

0.21

193

Other peripheral vascular diseases

242

2.76

13.07

1.8

2.5

0.95

1.21

e9/l

1.96

226

COPD-related respiratory insufficiency

329

2.49

13.04

1.6

2.0

1.26

1.09

e9/l

0.89

298

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

227

830

1.75

13.02

2.0

2.5

1.41

1.37

e9/l

0.35

198

729

Bronchitis, not specified as acute or chronic

260

2.68

12.96

2.6

2.5

1.29

1.17

e9/l

0.52

226

Polymyalgia rheumatica

342

2.45

12.95

2.0

1.20

1.06

e9/l

0.56

307

Microscopic polyangiitis

13.51

12.95

2.9

1.4

0.91

1.13

e9/l

0.46

Gout, unspecified

127

624

2.05

12.93

2.5

2.2

0.99

1.08

e9/l

0.66

116

575

Atrial fibrillation and flutter with reimbursement

153

495

1.98

12.91

2.4

2.8

0.97

1.09

e9/l

1.06

139

456

Depression or dysthymia

458

1716

1.48

12.88

2.7

2.3

1.27

1.16

e9/l

0.86

407

1542

Golimumab

105

3.79

12.87

1.5

3.0

1.29

1.28

e9/l

0.02

Other diseases of the digestive system

194

1101

1.77

12.70

2.3

2.4

1.08

1.13

e9/l

0.34

176

985

Inflammatory diseases of female pelvic organs

377

1834

1.52

12.68

2.1

2.3

1.35

1.28

e9/l

0.45

334

1631

Percutaneous Coronary Intervention

501

2139

1.44

12.61

2.0

2.6

1.11

1.23

e9/l

1.12

450

1914

Juvenile arthritis (FINNGEN)

161

3.16

12.52

2.0

3.9

1.30

1.29

e9/l

0.03

147

Focal epilepsy

162

875

1.86

12.51

2.4

2.7

1.11

1.21

e9/l

0.57

143

768

Psychiatric diseases

674

2463

1.37

12.47

2.7

2.4

1.26

1.18

e9/l

0.82

594

2196

Spondylopathies (FG)

100

455

2.22

12.44

1.6

2.7

1.25

1.24

e9/l

0.02

407

Postmenopausal osteoporosis with pathological fracture

122

3.49

12.37

2.4

1.4

0.99

e9/l

0.01

113

Focal epilepsy, strict definition

150

794

1.90

12.34

2.4

2.6

1.12

1.20

e9/l

0.46

133

695

Other inflammation of eyelid

445

2.22

12.27

2.6

2.4

1.11

1.16

e9/l

0.29

397

Phlebitis and thrombophlebitis (not including DVT)

151

803

1.89

12.26

2.2

2.4

1.14

1.18

e9/l

0.29

130

729

Dental caries, including avohilmo

478

1688

1.45

12.18

2.4

2.3

1.21

1.17

e9/l

0.36

425

1492

Psoriasis

192

1101

1.75

12.17

2.3

2.5

1.14

1.21

e9/l

0.52

176

982

COPD, hospital admissions

259

1352

1.63

12.09

1.7

2.3

1.21

1.09

e9/l

1.35

233

1239

Disorders of psychological development

119

542

2.06

12.04

3.4

2.7

1.40

e9/l

0.01

102

444

Varicella [chickenpox]

236

2.72

12.03

2.8

2.9

1.19

1.26

e9/l

0.19

203

Visual field defects

253

2.64

12.02

1.9

2.4

1.21

1.16

e9/l

0.22

229

Other and unspecified visual disturbances

319

2.44

11.93

2.2

2.3

1.25

1.21

e9/l

0.18

290

Ulcer of lower limb, not elsewhere classified

419

2.24

11.87

2.0

2.2

1.04

1.05

e9/l

0.05

385

Sciatica+with lumbago

317

1902

1.54

11.86

2.3

2.4

1.33

1.19

e9/l

1.25

290

1711

COPD, early/later onset

260

1361

1.62

11.85

1.7

2.3

1.21

1.09

e9/l

1.39

234

1246

Heart failure and coronary heart disease

247

1065

1.65

11.85

1.9

2.3

0.88

1.09

e9/l

5.01

228

963

Malnutrition

4.35

11.82

3.3

2.6

1.36

1.04

e9/l

0.60

Myeloproliferative diseases (CML excluded)

216

2.77

11.77

3.7

2.1

2.65

1.18

e9/l

0.41

196

Coronary revascularization (ANGIO or CABG)

495

2139

1.42

11.64

2.0

2.6

1.12

1.23

e9/l

1.05

444

1914

Invasive ventilation

246

2.64

11.63

2.3

2.5

1.39

1.24

e9/l

0.43

219

Ischemic heart diseases

524

2243

1.41

11.62

1.9

2.6

1.12

1.23

e9/l

1.11

477

2005

Deviated nasal septum

209

1242

1.69

11.61

2.0

2.5

1.29

1.10

e9/l

1.84

192

1131

Allergic purpura

3.96

11.60

1.9

2.4

1.02

1.27

e9/l

0.77

Conductive and sensorineural hearing loss

483

2302

1.42

11.51

2.3

2.5

1.16

1.18

e9/l

0.14

449

2070

Disorders of tooth development and eruption

116

460

2.05

11.50

2.7

2.4

1.39

1.28

e9/l

0.60

102

407

Nonpyogenic thrombosis of intracranial venous system

8.80

11.50

2.3

2.1

1.05

0.98

e9/l

0.12

Benign neoplasm of colon, rectum, anus and anal canal

367

2154

1.48

11.49

2.3

1.11

1.15

e9/l

0.30

329

1978

Focal epilepsy, mode (most common among epilepsy diagnosis)

140

743

1.90

11.47

2.4

2.6

1.12

1.20

e9/l

0.39

125

647

Bell's palsy

394

2.25

11.44

2.6

2.5

1.25

1.17

e9/l

0.35

357

Psoriasis vulgaris

131

681

1.94

11.44

2.4

1.10

1.22

e9/l

0.79

119

608

Benign neoplasm of other and ill-defined parts of digestive system

119

599

2.00

11.40

2.0

2.3

1.18

1.16

e9/l

0.10

104

544

Other juvenile arthritis

155

3.09

11.35

2.0

3.8

1.33

1.23

e9/l

0.30

139

Infections with a predominantly sexual mode of transmission

214

1289

1.67

11.30

2.6

2.4

1.39

1.29

e9/l

1.02

189

1129

Impetigo

177

2.93

11.27

2.7

2.8

1.44

1.32

e9/l

0.33

150

Benign neoplasm: Colon

311

1955

1.52

11.23

2.4

2.3

1.12

1.15

e9/l

0.20

279

1793

Allergic rhinitis

237

1455

1.62

11.15

2.1

2.8

1.41

1.28

e9/l

1.80

209

1252

Caries of dentine, including avohilmo

518

1887

1.41

11.12

2.4

1.22

1.18

e9/l

0.34

459

1658

Cystitis

531

2274

1.39

11.07

2.7

2.3

1.34

1.18

e9/l

3.21

462

2038

Gingivitis and periodontal diseases

679

2613

1.34

11.07

2.6

2.4

1.27

1.21

e9/l

0.58

597

2332

Migraine with aura

167

949

1.77

10.97

2.0

2.5

1.91

1.22

e9/l

0.65

152

826

Other follicular disorders

248

2.57

10.93

2.6

2.7

1.33

1.26

e9/l

0.24

223

Other diseases of intestine

441

2.15

10.90

2.5

2.4

1.15

1.13

e9/l

0.08

399

Need for other prophylactic measures

197

2.78

10.89

3.5

2.8

3.63

1.27

e9/l

0.46

177

Sleep apnoea

585

2788

1.36

10.85

2.0

2.5

1.27

1.17

e9/l

1.14

538

2491

Dependence on enabling machines and devices, not elsewhere classified

5.09

10.78

2.7

1.8

1.35

1.53

e9/l

0.22

Non-selective monoamine reuptake inhibitors

229

1370

1.62

10.75

1.8

2.3

1.39

1.20

e9/l

1.31

204

1253

Cardiomyopathy

105

517

2.04

10.71

2.2

2.6

1.04

1.13

e9/l

0.47

463

Vulvovaginal ulceration/inflammation in other diseases

199

2.75

10.68

2.5

2.4

1.39

1.29

e9/l

0.31

175

Thyroiditis, ILD-related definition

330

2.32

10.64

2.0

2.2

1.15

1.32

e9/l

0.86

285

Diseases of pulp and periapical tissues and dental caries

420

1491

1.45

10.58

2.4

2.2

1.20

1.17

e9/l

0.21

374

1312

Irregular menses

301

1567

1.52

10.55

2.8

2.2

1.33

1.26

e9/l

0.85

271

1385

Ascites

201

2.72

10.47

2.1

2.2

0.87

1.08

e9/l

1.09

180

Congenital malformations of trachea and bronchus

5.39

10.45

2.6

3.6

1.77

1.28

e9/l

0.79

Special screening examination for other diseases and disorders

271

2.45

10.44

2.3

2.0

1.36

1.15

e9/l

1.20

248

Type 2 diabetes, wide definition

485

2231

1.40

10.43

2.1

2.5

1.23

1.19

e9/l

0.27

444

2014

Emergency coronary revascularization (for ACS)

520

2295

1.38

10.43

2.0

2.6

1.10

1.21

e9/l

1.17

467

2062

Unspecified chronic bronchitis

3.90

10.41

1.8

2.0

1.24

1.20

e9/l

0.08

Major coronary heart disease event

516

2259

1.38

10.39

2.0

2.6

1.11

1.22

e9/l

1.12

463

2027

Cholangitis (primary sclerosing, PSC)

180

2.81

10.34

1.8

2.5

0.95

1.22

e9/l

1.44

160

Disorders of synovium and tendon

332

1971

1.48

10.34

2.5

2.4

1.33

1.20

e9/l

0.94

301

1759

Melanocytic naevi

198

1200

1.66

10.32

2.3

2.5

1.14

1.23

e9/l

0.81

174

1062

Atopic dermatitis, strict definition

227

1400

1.60

10.12

2.6

1.35

1.33

e9/l

0.15

195

1208

In situ neoplasms

221

1384

1.60

10.10

2.4

2.3

1.15

1.17

e9/l

0.15

196

1244

Abnormal involuntary movements

455

2.08

10.09

2.5

2.4

1.45

1.16

e9/l

1.25

406

Other chronic obstructive pulmonary disease, including avohilmo

304

1681

1.50

10.02

1.7

2.4

1.19

1.10

e9/l

1.02

275

1534

Other congenital malformations

404

2.15

10.00

3.9

2.9

1.32

1.38

e9/l

0.20

337

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

198

1211

1.64

9.98

2.2

2.5

1.39

1.28

e9/l

1.14

164

1078

Gout, strict definition

110

566

1.96

9.96

2.4

2.2

1.04

1.09

e9/l

0.24

523

Other CVD

113

587

1.94

9.93

1.7

2.2

1.11

1.10

e9/l

0.03

101

538

Conduction disorders

169

797

1.73

9.93

2.1

2.6

1.00

1.17

e9/l

2.09

155

720

Herpesviral keratitis and keratoconjunctivitis

105

3.38

9.88

3.0

2.1

1.15

1.22

e9/l

0.19

Lumbar disc prolapse

386

2076

1.43

9.88

2.3

2.4

1.35

1.19

e9/l

1.63

354

1866

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

139

749

1.81

9.86

2.3

2.8

1.19

1.31

e9/l

0.75

119

635

Abnormalities of gait and mobility

394

2.15

9.81

2.6

2.2

1.27

1.13

e9/l

0.75

352

Migraine with aura and triptan purchases

116

612

1.91

9.77

2.0

2.6

1.34

1.29

e9/l

0.32

104

526

Malignant melanoma, including Hilmo

311

2.29

9.75

2.7

2.0

1.06

1.13

e9/l

0.38

282

Pruritus

337

2.24

9.73

2.3

2.2

1.28

1.18

e9/l

0.54

298

Triptan medication for migraine, min. 3 purchases

366

1946

1.44

9.71

2.2

2.5

1.37

1.25

e9/l

1.87

326

1722

Diseases of inner ear

310

2039

1.48

9.66

2.1

2.4

1.17

1.19

e9/l

0.13

287

1830

Dizziness and giddiness

462

2667

1.38

9.55

2.3

2.4

1.30

1.18

e9/l

1.44

421

2392

Paralytic strabismus

217

2.56

9.55

2.8

2.4

1.27

1.17

e9/l

0.45

194

Allergic urticaria

296

2.32

9.53

2.5

2.9

1.44

1.30

e9/l

0.55

267

Cholelithiasis, broad definition with cholecystitis

518

2576

1.36

9.52

2.3

2.4

1.17

1.20

e9/l

0.24

465

2325

Speech and linguistic disorders

440

2.05

9.50

4.1

2.7

1.53

1.40

e9/l

0.41

354

Hernia

581

2929

1.33

9.48

2.5

2.4

1.36

1.18

e9/l

0.57

530

2604

Pain associated with micturition

387

2.14

9.44

3.4

2.3

1.33

1.18

e9/l

1.12

348

Unspecified haematuria

246

1324

1.55

9.39

2.4

2.3

1.16

1.13

e9/l

0.20

221

1204

Other disorders of conjunctiva

470

2.02

9.28

2.3

2.4

1.17

1.12

e9/l

0.20

426

Oesophageal varices

120

3.13

9.24

1.5

2.5

0.80

1.17

e9/l

1.86

104

Otitis externa, unspecified

417

2.08

9.24

2.7

1.33

1.24

e9/l

0.47

364

Cerebral cysts

180

2.70

9.23

2.4

2.6

1.39

1.24

e9/l

0.45

164

Neuralgia and neuritis, unspecified

158

2.82

9.19

1.8

2.5

1.46

1.18

e9/l

1.05

148

Migraine without aura and triptan purchases

120

654

1.85

9.17

2.2

2.5

1.41

1.30

e9/l

0.66

103

561

Smoking dependency

303

2.27

9.05

2.6

2.5

1.50

1.21

e9/l

1.72

283

Mental and behavioural disorders due to tobacco

303

2.27

9.05

2.6

2.5

1.50

1.20

e9/l

1.83

282

COPD related to multimorbidity

212

1135

1.58

9.03

1.7

2.3

1.16

1.08

e9/l

0.70

192

1036

Strabismus

193

1202

1.61

9.01

3.0

2.7

1.25

1.27

e9/l

0.13

175

1034

Disorders of vestibular function (Vertigo)

262

1722

1.50

8.98

2.2

2.4

1.20

1.21

e9/l

0.07

241

1549

Nummular dermatitis

236

2.44

8.96

3.3

2.5

1.21

1.13

e9/l

0.23

214

Rosacea

409

2.07

8.94

2.3

1.21

1.23

e9/l

0.08

366

Hypothyroidism, other/unspecified

549

2721

1.33

8.86

2.3

2.4

1.19

1.22

e9/l

0.29

492

2429

Injuries to the abdomen, lower back, lumbar spine and pelvis

238

1547

1.53

8.85

2.4

1.54

1.20

e9/l

0.40

213

1378

Personal history of malignant neoplasm

184

2.64

8.85

2.4

2.2

1.32

1.17

e9/l

0.75

164

Persons encountering health services in circumstances related to reproduction

392

1889

1.40

8.85

2.7

1.39

1.21

e9/l

3.13

341

1673

Paroxysmal tachycardia

139

664

1.76

8.84

1.9

3.0

1.09

1.20

e9/l

0.93

124

597

Motor disorders, excluding more controls

3.34

8.82

3.4

2.9

1.70

1.57

e9/l

0.19

Sensorineural hearing loss

437

2163

1.37

8.80

2.3

2.5

1.16

e9/l

0.01

407

1956

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

140

786

1.74

8.74

2.3

2.8

1.20

1.30

e9/l

0.52

120

664

Colonic or urogenital fistula

172

1053

1.64

8.71

2.3

2.4

1.20

1.19

e9/l

0.04

149

945

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

186

2.63

8.68

3.6

3.5

1.38

1.36

e9/l

0.03

149

Pyoderma gangrenosum

9.44

8.66

1.7

0.95

1.36

e9/l

0.82

Cholelithiasis

491

2521

1.35

8.66

2.3

2.4

1.17

1.20

e9/l

0.20

440

2274

Other disorders of eyelid

235

1473

1.52

8.63

2.4

2.2

1.20

1.17

e9/l

0.10

213

1330

Other retinal disorders

355

1962

1.41

8.61

2.1

2.4

1.06

1.20

e9/l

1.32

325

1773

Perforation of tympanic membrane

329

2.18

8.60

2.3

2.5

1.17

1.19

e9/l

0.09

295

External causes of morbidity and mortality

445

1623

1.38

8.57

2.4

1.28

1.20

e9/l

0.92

393

1432

Fracture of lumbar spine and pelvis

124

697

1.79

8.53

2.4

2.3

1.03

1.14

e9/l

0.85

115

631

Psoriatic and enteropathic arthropathies

363

2.11

8.52

1.6

2.8

1.16

1.21

e9/l

0.17

332

Seronegative juvenile rheumatoid arthritis

3.76

8.51

2.5

3.8

1.18

1.46

e9/l

0.82

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

3.36

8.48

2.2

2.1

1.12

e9/l

0.01

Hypotension

465

1.97

8.47

1.6

2.1

1.17

1.09

e9/l

0.35

423

Parapsoriasis

4.38

8.45

1.6

2.4

1.60

1.26

e9/l

0.45

Other diseases of liver

119

666

1.80

8.38

2.5

1.27

1.20

e9/l

0.40

103

592

Other diseases of anus and rectum

168

1031

1.63

8.36

2.2

2.4

1.10

1.14

e9/l

0.29

148

926

Polycystic ovarian syndrome, consortium definition

417

1797

1.38

8.35

2.6

2.2

1.30

1.29

e9/l

0.07

381

1590

Hypothyreosis and Thyroxine purchase for inclusion criteria

559

2801

1.31

8.24

2.3

2.4

1.19

1.22

e9/l

0.34

501

2499

malignant neoplasm of male genital organs

113

370

1.87

8.22

2.5

2.2

1.06

1.08

e9/l

0.07

102

340

Disorders of muscles

342

2.12

8.21

1.9

2.6

1.18

1.14

e9/l

0.14

308

Malignant neoplasm of prostate, including Hilmo

111

352

1.88

8.21

2.6

2.2

1.02

1.05

e9/l

0.08

101

324

Anomalies of dental arch relationship, including avohilmo

152

823

1.68

8.21

2.9

2.6

1.21

1.33

e9/l

0.97

138

706

Delayed milestone in childhood

183

2.57

8.20

3.6

4.0

1.52

1.55

e9/l

0.06

136

Congenital malformations and deformations of the musculoskeletal system

462

1.96

8.20

2.2

2.8

1.51

1.37

e9/l

0.78

378

Tuberculosis, IBD comorbidity

168

2.64

8.19

1.9

2.0

1.41

1.03

e9/l

1.02

151

Endocrine disorders, other/unspecified

4.44

8.19

4.5

2.0

1.17

1.31

e9/l

0.29

Acute nasopharyngitis (common cold)

353

2.10

8.18

2.3

2.6

1.26

1.22

e9/l

0.19

317

STROKE

333

1600

1.42

8.11

2.3

2.7

1.16

1.19

e9/l

0.24

299

1441

Other disorders of kidney and ureter

446

1.97

8.07

2.6

2.3

1.20

1.09

e9/l

0.38

401

Emphysema

187

2.54

8.06

1.8

2.2

1.02

e9/l

0.02

164

Malignant neoplasm of breast, ER-negative, including Hilmo

410

1.98

8.06

2.5

2.1

1.05

1.45

e9/l

0.96

366

Malignant melanoma

254

2.30

8.05

2.8

2.1

0.99

1.10

e9/l

0.63

230

Adverse effects, not elsewhere classified

143

854

1.68

8.03

2.1

2.6

1.38

1.24

e9/l

1.08

124

742

Excessive, frequent and irregular menstruation

242

876

1.52

7.99

2.7

2.1

1.29

1.24

e9/l

0.44

222

774

Spirochaetal infections, other/unspecified

294

2.20

7.97

1.9

2.2

1.17

1.19

e9/l

0.08

267

Coeliac disease

469

1.93

7.97

2.8

2.7

1.20

e9/l

0.02

412

Chronic suppurative otitis media, including avohilmo

288

2.21

7.94

2.3

2.6

1.41

1.24

e9/l

0.76

247

Diseases of pulp and periapical tissues, including avohilmo

676

2744

1.28

7.88

2.4

1.25

1.23

e9/l

0.17

610

2426

Post-traumatic stress disorder

289

2.20

7.86

2.4

2.5

1.59

1.24

e9/l

2.45

252

Anogenital herpesviral [herpes simplex] infection

214

2.41

7.84

2.4

2.5

1.25

e9/l

0.00

188

Alopecia areata

3.44

7.84

2.5

2.8

1.14

1.26

e9/l

0.34

Migraine, single triptan purchase ok & required. ICD-code if available is included

485

2483

1.33

7.78

2.4

2.5

1.36

1.20

e9/l

4.57

433

2205

Triptan medication for migraine, single purchase ok

485

2483

1.33

7.78

2.4

2.5

1.36

1.20

e9/l

4.57

433

2205

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

115

654

1.77

7.72

2.0

2.4

1.25

1.22

e9/l

0.12

103

576

Other external causes of accidental injury

552

2115

1.31

7.71

2.4

2.5

1.27

1.19

e9/l

1.16

484

1882

Unspecified fall

307

2149

1.41

7.71

2.2

2.5

1.22

1.21

e9/l

0.13

277

1895

Pollen allergy

156

951

1.63

7.70

2.3

2.9

1.44

1.33

e9/l

0.82

135

803

Other disorders starting during childhood or adolecense, excluding more controls

218

2.36

7.69

4.4

2.8

1.39

1.43

e9/l

0.08

167

Other disorders of bladder

385

2.02

7.68

2.4

2.3

1.35

1.10

e9/l

1.14

355

Crossbite

355

2.03

7.67

3.5

3.1

1.39

1.31

e9/l

0.29

293

Paracetamol or NSAID medication

115

316

1.84

7.67

3.3

3.0

1.34

1.14

e9/l

1.01

278

Ulcerative colitis (strict definition, require KELA)

117

670

1.76

7.67

2.0

2.4

1.25

1.22

e9/l

0.12

105

590

Disease of hard tissues of teeth, NOS

306

1117

1.44

7.64

2.4

2.2

1.26

1.24

e9/l

0.08

270

1001

Malignant neoplasm of breast, HER-negative

358

2.04

7.63

2.5

2.1

1.06

1.46

e9/l

0.81

321

Accidents

551

2115

1.31

7.60

2.4

2.5

1.29

1.19

e9/l

1.55

483

1882

Other congenital malformations

105

586

1.81

7.52

3.6

2.6

1.35

1.33

e9/l

0.05

495

Lichen simplex chronicus and prurigo

164

2.59

7.52

2.1

1.18

1.11

e9/l

0.22

150

Otalgia

295

2.16

7.50

3.1

2.7

1.28

1.20

e9/l

0.30

257

Cardiomyopathies, Primary/intrinsic

348

2.05

7.49

2.4

2.5

0.89

1.18

e9/l

2.40

319

Hyperparathyroidism

509

1.85

7.45

2.4

2.2

1.08

1.15

e9/l

0.31

458

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

124

728

1.71

7.45

2.0

2.5

1.25

1.22

e9/l

0.13

111

643

Ankylosing spondylitis

309

2.12

7.44

1.8

2.5

1.18

1.11

e9/l

0.23

282

Diseases of external ear

213

1423

1.50

7.44

2.3

2.5

1.28

1.20

e9/l

0.69

189

1262

Other coagulation defects

232

2.31

7.42

2.4

1.14

1.25

e9/l

0.45

208

Short stature, not elsewhere classified

198

2.42

7.41

5.2

3.3

1.69

1.49

e9/l

0.53

146

Tuberculosis

142

2.70

7.41

1.7

2.0

1.27

1.10

e9/l

0.30

127

Alzheimer disease, including avohilmo

783

0.46

7.41

2.5

1.8

0.97

1.05

e9/l

0.40

720

Other Crohn's disease

226

2.32

7.41

2.4

2.8

0.96

1.27

e9/l

2.03

202

Ankylosing spondylitis, ICD10

310

2.12

7.39

1.8

2.7

1.18

1.21

e9/l

0.08

283

Colectomy operation

100

553

1.82

7.39

2.2

2.3

1.29

1.09

e9/l

0.74

497

Disorders of the thyroid gland

576

2926

1.28

7.30

2.4

1.20

1.21

e9/l

0.15

517

2616

Amenorrhoea

253

2.23

7.29

4.1

2.2

1.25

1.30

e9/l

0.20

214

Specific development disorders of scholastic skills

231

2.30

7.29

5.6

2.7

1.53

1.36

e9/l

0.44

185

Chronic suppurative otitis media

209

2.37

7.28

2.5

2.4

1.40

1.26

e9/l

0.44

183

Malignant neoplasm of prostate

103

335

1.85

7.26

2.4

2.2

1.06

1.05

e9/l

0.02

307

Tuberculosis, wide

179

2.48

7.24

1.9

2.1

1.41

1.08

e9/l

0.82

160

Spinal stenosis

269

1425

1.44

7.23

2.1

2.3

1.18

1.16

e9/l

0.09

248

1305

Other local infections of skin and subcutaneous tissue

353

2.03

7.23

3.7

2.7

1.17

1.18

e9/l

0.04

314

DVT of lower extremities

107

608

1.77

7.22

2.3

2.4

1.18

1.16

e9/l

0.08

552

COPD, hospital admissions 1, only main diagnosis

178

981

1.56

7.22

1.8

2.2

1.21

1.10

e9/l

1.02

159

895

Use of anticholinesterases

821

0.45

7.20

2.4

1.8

1.27

1.06

e9/l

0.56

754

N06DA Anticholinesterases

821

0.45

7.20

2.4

1.8

1.27

1.06

e9/l

0.56

754

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

211

1418

1.49

7.18

2.5

2.6

1.26

1.21

e9/l

0.23

187

1257

Hydronephrosis

327

2.06

7.17

2.4

0.87

1.10

e9/l

2.35

293

Otitis externa

146

905

1.62

7.14

2.5

2.6

1.32

1.22

e9/l

0.73

131

794

Haemorrhoids and perianal venous thrombosis

169

1085

1.56

7.04

2.2

2.3

1.13

e9/l

0.02

149

979

Bullous disorders

152

2.59

7.03

1.9

2.1

1.00

1.16

e9/l

0.79

137

Bacterial, viral and other infectious agents

323

2.06

7.03

2.3

2.9

1.21

1.29

e9/l

0.37

295

Pacemaker

165

1011

1.57

7.03

2.0

2.1

0.94

1.07

e9/l

1.44

151

919

Other diseases of biliary tract

251

2.21

7.00

1.7

2.3

1.03

1.15

e9/l

0.44

225

Other and unspecified effects of external causes

185

1217

1.53

6.99

2.2

2.7

1.32

1.25

e9/l

0.54

161

1061

Seborrhoeic keratosis

121

719

1.69

6.98

2.3

1.24

1.11

e9/l

0.78

114

659

Sleep apnoea, including avohilmo

594

2898

1.27

6.93

2.1

2.5

1.28

1.18

e9/l

1.27

545

2588

Coxarthrosis [arthrosis of hip](FG)

262

1288

1.43

6.92

2.2

2.4

1.13

1.16

e9/l

0.18

239

1184

Allergic contact dermatitis

478

1.85

6.92

1.5

2.5

1.23

e9/l

0.04

429

Injury, poisoning and certain other consequences of external causes

363

1332

1.37

6.87

2.5

2.4

1.29

1.21

e9/l

0.76

318

1166

Other or ill-defined heart diseases

148

2.59

6.86

2.3

2.7

1.03

1.28

e9/l

0.84

129

Dermatographic urticaria

215

2.30

6.86

2.8

2.4

1.60

1.27

e9/l

1.63

194

Substance use, excluding alcohol

131

799

1.65

6.85

2.4

2.5

1.47

1.24

e9/l

2.20

115

710

Colorectal cancer

385

1.94

6.85

1.8

1.9

1.16

1.08

e9/l

0.18

348

Cardiomyopathy (excluding other)

374

1.96

6.84

2.4

0.88

1.16

e9/l

2.38

338

Gonarthrosis [arthrosis of knee](FG)

377

1623

1.35

6.83

2.2

2.5

1.23

1.18

e9/l

0.48

340

1478

Sleep disorders (combined)

701

2952

1.25

6.80

2.1

2.5

1.30

1.19

e9/l

1.57

628

2637

Other and unspecified rosacea

274

2.14

6.79

2.4

1.22

1.20

e9/l

0.04

252

Infective dermatitis

341

2.01

6.78

2.3

2.4

0.94

1.14

e9/l

1.83

308

Other predominantly sexually transmitted diseases, not elsewhere classified

115

680

1.70

6.78

2.5

2.4

1.46

1.30

e9/l

1.06

105

594

Pain and other conditions associated with female genital organs and menstrual cycle

129

720

1.65

6.77

1.9

2.1

1.36

1.26

e9/l

0.76

115

631

Other bursopathies

439

1.88

6.75

2.1

2.5

1.10

1.12

e9/l

0.07

404

Other erythematous conditions

3.02

6.67

2.1

2.5

1.04

1.25

e9/l

0.68

Hyperlipidaemia, other/unspecified

202

1256

1.49

6.66

2.2

2.4

1.13

1.08

e9/l

0.40

191

1144

Other female pelvic inflammatory diseases

100

572

1.76

6.64

2.1

2.4

1.37

1.21

e9/l

1.25

508

Other disorders of nervous system

206

2.30

6.61

2.0

2.3

1.26

1.16

e9/l

0.31

190

Excessive attrition of teeth

346

2580

1.34

6.55

2.3

2.5

1.19

1.21

e9/l

0.15

302

2295

Infections with a predominantly sexual mode of transmission

250

1645

1.42

6.53

2.5

2.4

1.37

1.28

e9/l

1.03

219

1442

Other bullous disorders

3.34

6.44

2.0

2.2

1.02

1.25

e9/l

0.67

Tooth eruption problems

111

643

1.69

6.43

3.3

2.8

1.49

1.32

e9/l

1.33

550

Nocardiosis

+∞

6.43

4.7

0.0

1.28

—

e9/l

—

Other specified/unspecified bacterial intestinal infections

190

2.34

6.41

2.5

2.3

1.39

1.15

e9/l

0.66

173

Bacterial, viral and other infectious agents

302

2.04

6.34

2.4

2.9

1.20

1.27

e9/l

0.26

277

Disorders of vitreous body and globe

271

1876

1.39

6.33

2.3

1.18

1.16

e9/l

0.13

247

1706

Other nutritional deficiencies

403

2903

1.31

6.33

2.1

2.5

1.35

1.19

e9/l

3.23

364

2583

Acute posthaemorrhagic anaemia

3.48

6.30

2.4

2.0

1.00

1.22

e9/l

0.61

Cardiomyopathy, other and unspecified

217

2.23

6.29

2.5

2.6

0.95

1.21

e9/l

1.63

194

Other and unspecified coagulation defects

149

2.51

6.28

2.4

2.7

1.12

1.30

e9/l

0.54

140

Other and unspecified local infections of skin and subcutaneous tissue

338

1.97

6.25

3.8

2.6

1.17

1.20

e9/l

0.10

300

Total colectomy

126

2.65

6.24

2.2

2.6

1.46

1.28

e9/l

0.39

116

Total colectomy operation

126

2.65

6.24

2.2

2.6

1.46

1.28

e9/l

0.39

116

Disorders of vitreous body

264

1835

1.39

6.24

2.3

1.20

1.16

e9/l

0.19

241

1672

Arthrosis

390

1614

1.33

6.24

2.2

2.5

1.27

1.15

e9/l

1.75

351

1450

AV-block

431

1.80

6.21

2.0

2.4

0.97

1.09

e9/l

0.73

393

Congenital malformations of great arteries

178

2.39

6.20

2.2

3.7

1.02

1.57

e9/l

3.64

132

Other keratitis

409

1.87

6.20

3.3

2.4

1.41

1.23

e9/l

0.87

358

Congenital iodine-deficiency syndrome/hypothyroidism

3.16

6.19

1.6

2.1

1.43

1.11

e9/l

0.49

Spondylosis

289

1717

1.38

6.18

2.2

2.4

1.22

1.16

e9/l

0.37

263

1561

Obesity due to excess calories

286

2093

1.37

6.15

2.2

2.5

1.38

1.20

e9/l

2.96

264

1858

Myopia

513

1.77

6.10

2.6

2.4

1.32

1.26

e9/l

0.28

442

Abscess of anal and rectal regions

293

2.03

6.09

1.9

2.9

1.08

1.17

e9/l

0.36

265

Nonorganic sleeping disorders, excluding more controls

114

693

1.65

6.09

2.1

2.4

1.41

1.23

e9/l

0.96

606

Other benign neoplasms of skin

204

1411

1.45

6.08

2.0

2.4

1.63

1.16

e9/l

0.49

183

1269

Pain in thoracic spine

529

1.75

6.04

2.1

2.5

1.27

1.15

e9/l

0.66

476

Other and unspecified erythematous conditions

2.96

6.02

2.2

2.6

1.09

1.24

e9/l

0.39

Other arthrosis

276

1384

1.38

6.01

1.9

2.5

1.26

1.12

e9/l

1.53

252

1252

Nasal polyp

109

658

1.66

5.99

2.2

2.5

1.34

1.13

e9/l

1.79

601

Presence of other devices

117

716

1.63

5.99

2.2

2.1

1.25

1.11

e9/l

0.73

109

655

Crowding of teeth, including avohilmo

381

1.82

5.97

3.0

1.41

1.36

e9/l

0.18

313

Benign neoplasm: Small intestine

106

2.77

5.97

2.1

1.7

1.05

1.19

e9/l

0.34

Hepatic failure, not elsewhere classified

2.88

5.96

1.7

2.2

1.07

1.16

e9/l

0.22

Malignant neoplasm of breast, HER2-negative, including Hilmo

170

728

1.52

5.91

2.3

2.1

1.11

1.38

e9/l

1.12

155

642

Malignant neoplasm of breast, including Hilmo

170

728

1.52

5.90

2.3

2.1

1.11

1.38

e9/l

1.12

155

642

Respiratory tuberculosis

124

2.60

5.88

1.6

2.0

1.45

1.12

e9/l

0.55

112

Respiratory tuberculosis, confirmed and not-confirmed

124

2.60

5.88

1.6

2.0

1.45

1.12

e9/l

0.55

112

Intestinal adhesions without obstruction

230

2.15

5.88

2.1

1.12

1.09

e9/l

0.09

207

Infectious mononucleosis

312

1.97

5.82

2.8

2.7

1.16

1.26

e9/l

0.46

266

Fall on same level

731

3285

1.22

5.71

2.2

2.5

1.24

e9/l

0.03

649

2917

Specific developmental disorder of motor function

130

2.56

5.68

3.4

2.9

1.70

1.52

e9/l

0.29

Peritonsillar abscess

122

769

1.59

5.66

2.3

2.7

1.29

1.18

e9/l

0.92

109

673

Benign neoplasm: Colon, unspecified

132

849

1.56

5.62

2.5

2.3

1.03

1.10

e9/l

0.39

121

777

Dystonia

170

2.32

5.61

2.8

2.2

1.28

1.22

e9/l

0.18

153

Retinal detachments and breaks

180

1236

1.46

5.61

2.1

2.3

1.15

1.13

e9/l

0.18

162

1122

Diseases of male genital organs

324

1218

1.35

5.60

2.9

2.6

1.20

1.14

e9/l

0.49

297

1070

Cerebrovascular diseases

402

2188

1.29

5.59

2.3

2.4

1.39

1.13

e9/l

0.54

359

1987

Hydrocele

373

1.86

5.59

2.4

2.6

1.11

1.04

e9/l

0.31

332

Exposure to other specified factors

463

3366

1.26

5.59

2.4

2.5

1.27

1.20

e9/l

1.20

407

2991

Corneal ulcer

111

687

1.62

5.57

2.5

1.25

1.20

e9/l

0.24

101

599

Falls/tendency to fall

700

2877

1.22

5.55

2.3

2.5

1.29

1.20

e9/l

1.71

622

2548

Inflammatory disease of uterus

513

1.73

5.55

1.8

2.5

1.47

1.28

e9/l

1.28

448

Other and unspecified nerve root and plexus disorders, also in other diseases

118

743

1.60

5.52

2.2

2.5

1.32

1.19

e9/l

0.94

107

669

Malignant neoplasm of breast, HER2-negative

161

701

1.51

5.48

2.2

2.1

1.10

1.38

e9/l

1.12

146

622

Chondropathies

583

1.67

5.47

3.1

2.4

1.41

1.23

e9/l

1.38

516

Left ventricular outflow tract obstruction (LVOTO), broad definition

405

1.82

5.47

2.5

3.0

0.97

1.25

e9/l

2.04

358

Congenital malformations and deformations of the musculoskeletal system

558

1.69

5.45

2.2

2.7

1.49

1.36

e9/l

0.69

463

Congenital malformations of the circulatory system

111

670

1.62

5.45

2.9

2.8

1.10

1.33

e9/l

2.21

566

Cluster headache, wide,, including avohilmo

160

2.34

5.43

1.4

2.5

1.54

1.29

e9/l

0.90

147

Phobic anxiety disorders

516

1.71

5.41

2.6

1.46

1.27

e9/l

1.41

447

Infarction of spleen

8.20

5.41

2.2

1.3

1.70

1.21

e9/l

—

Early syphilis

3.81

5.40

3.9

2.4

1.79

1.31

e9/l

1.55

Cervical disc disorders

195

1370

1.43

5.39

2.1

2.4

1.43

1.11

e9/l

3.24

172

1249

Amputation

279

1.98

5.39

1.5

2.0

1.02

1.11

e9/l

0.39

251

Heartburn

328

1.90

5.38

2.3

2.6

1.35

1.18

e9/l

0.88

294

Congenital malformations of heart and great arteries

104

620

1.64

5.36

2.4

2.9

1.06

1.33

e9/l

3.02

521

Disorders of continuity of bone

329

1.90

5.34

2.9

2.4

1.19

1.22

e9/l

0.10

296

Cluster headache, strict, including avohilmo

155

2.35

5.34

1.4

2.5

1.52

1.31

e9/l

0.68

143

Pure hypercholesterolaemia

384

1940

1.29

5.33

2.1

2.5

1.26

1.11

e9/l

2.03

343

1757

Caries of enamel

549

3205

1.24

5.33

2.7

2.4

1.30

1.24

e9/l

0.67

461

2886

D07AA Corticosteroids, weak (group I)

113

710

1.60

5.32

2.7

1.36

1.32

e9/l

0.13

601

Nonischemic cardiomyopathy

315

1.92

5.32

2.9

2.5

0.90

1.17

e9/l

2.14

282

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

154

921

1.49

5.30

2.6

2.8

1.45

1.38

e9/l

0.39

130

782

Presence of cardiac and vascular implants and grafts

203

1063

1.42

5.30

1.8

2.1

0.96

1.09

e9/l

1.62

182

966

Malignant neoplasm of breast

163

715

1.49

5.29

2.4

2.1

1.12

1.38

e9/l

1.04

148

635

Scoliosis

309

1.92

5.29

2.1

2.5

1.24

1.16

e9/l

0.25

272

Erosion of teeth , including avohilmo

160

1090

1.47

5.24

2.5

2.6

1.30

1.24

e9/l

0.28

135

950

Fracture of foot, except ankle

152

1025

1.49

5.23

2.4

2.6

1.27

1.23

e9/l

0.21

126

894

Exclusions for E4_PCOS_CONSORTIUM

434

2143

1.27

5.19

2.4

2.5

1.28

1.29

e9/l

0.08

390

1885

Other sleep disorders

376

1.82

5.16

2.0

2.6

1.45

1.11

e9/l

1.40

334

Elevated blood glucose level

277

1.96

5.16

2.3

2.7

1.24

1.20

e9/l

0.09

245

Selective serotonin reuptake inhibitors

599

2550

1.23

5.15

2.4

1.27

1.18

e9/l

0.96

518

2294

Insulin, fast-acting

216

1558

1.39

5.14

2.1

2.6

1.13

1.21

e9/l

0.79

192

1377

Hallux valgus (acquired)

167

820

1.47

5.14

2.1

2.4

1.10

1.15

e9/l

0.30

155

742

Injuries to the ankle and foot

434

3066

1.26

5.11

2.4

2.5

1.27

1.21

e9/l

0.87

377

2723

Intermittent heterotropia

278

1.96

5.10

2.9

2.7

1.23

1.39

e9/l

0.78

228

Insulin, fast-acting or short human

218

1582

1.38

5.02

2.1

2.6

1.13

1.21

e9/l

0.67

194

1397

Hypermetropia

301

1.91

5.01

3.4

2.6

1.51

1.34

e9/l

0.45

254

Cholecystectomy

382

2586

1.28

4.99

2.3

1.22

1.20

e9/l

0.17

344

2329

Pleural plaque

239

2.02

4.99

2.0

1.08

e9/l

0.01

216

Other hammer toe(s) (acquired)

445

1.71

4.98

2.0

2.3

1.26

1.13

e9/l

0.32

401

Degenerative diseases of the nervous system

791

0.56

4.95

2.4

1.9

0.98

1.06

e9/l

0.46

723

Cluster headache, strict

2.69

4.92

1.4

2.7

1.53

1.24

e9/l

0.71

Periodontitis

550

3001

1.23

4.92

2.5

2.4

1.22

1.19

e9/l

0.26

501

2692

Adjustment and management of implanted device

471

1.71

4.91

1.7

2.4

0.98

1.10

e9/l

0.77

419

Malignant neoplasm of tongue, including Hilmo

3.52

4.91

2.3

1.8

0.88

1.29

e9/l

0.90

Insulin, combination of fast acting with intermediate-acting or long-acting

346

2460

1.29

4.89

2.2

2.5

1.09

1.17

e9/l

1.10

310

2198

Transport accidents

279

1812

1.33

4.89

2.2

2.5

1.29

1.17

e9/l

1.74

240

1619

Malignant neoplasm of oral cavity

3.36

4.89

1.7

2.2

0.88

1.29

e9/l

0.88

Type of accident

171

1197

1.43

4.88

2.2

2.5

1.78

1.21

e9/l

0.51

155

1063

Disorders of speech understanding and production

217

2.06

4.86

2.8

3.4

1.56

1.45

e9/l

0.24

168

Other predominantly sexually transmitted diseases, not elsewhere classified

128

847

1.52

4.86

2.5

2.4

1.47

1.30

e9/l

1.26

116

742

Benign neoplasm: Stomach

298

1.89

4.82

1.8

2.0

1.16

1.10

e9/l

0.20

267

Open wound of lower leg

550

1.64

4.82

2.0

2.5

1.08

1.18

e9/l

0.58

481

Degeneration of macula and posterior pole

221

1283

1.37

4.80

2.1

2.2

1.04

1.17

e9/l

0.81

204

1167

Mucosal proctocolitis

490

1.68

4.79

2.4

2.5

1.14

1.23

e9/l

0.34

434

Unspecific neurodegenerative disorder

928

0.61

4.78

2.3

1.9

1.13

1.06

e9/l

0.24

847

Chronic periodontitis, including avohilmo

547

3000

1.22

4.77

2.5

2.4

1.22

1.19

e9/l

0.24

498

2692

Personal history of other diseases and conditions

474

1.69

4.74

3.4

2.3

1.46

1.35

e9/l

0.45

397

Superficial injury of lower leg

147

1006

1.47

4.74

1.9

2.6

1.21

1.22

e9/l

0.05

134

885

Coxarthrosis

242

1180

1.36

4.74

2.2

2.4

1.13

1.12

e9/l

0.10

219

1079

Ovarian cyst

202

832

1.40

4.74

2.1

1.33

1.23

e9/l

0.88

179

735

Injuries to the wrist and hand

612

3513

1.21

4.74

2.2

2.5

1.26

1.21

e9/l

0.47

550

3124

Viral hepatitis

265

1.94

4.73

3.1

2.7

1.39

1.25

e9/l

0.40

243

Injuries to the thorax

243

1814

1.34

4.70

2.3

2.4

1.26

1.14

e9/l

1.34

214

1631

Trigeminal neuralgia

158

2.23

4.69

2.8

2.2

1.33

1.17

e9/l

0.53

143

Motor disorders

146

2.32

4.66

3.4

3.7

1.70

1.45

e9/l

0.45

108

Supplementary factors related to causes of morbidity and mortality classified elsewhere

183

1309

1.40

4.65

2.4

2.5

1.75

1.22

e9/l

0.51

165

1163

Speech disturbances, not elsewhere classified

239

1.98

4.63

2.0

2.2

1.16

1.17

e9/l

0.04

217

Ulcerative colitis (strict definition, all Crohn cases excluded)

572

1.62

4.62

2.1

2.4

1.20

1.22

e9/l

0.08

504

Heterophoria

310

1.85

4.61

3.7

2.7

1.22

1.28

e9/l

0.20

272

Obsessive-compulsive disorder

219

2.02

4.61

2.5

2.6

1.35

1.29

e9/l

0.17

190

ILD medications: nintedanib

14.45

4.61

1.4

2.2

1.04

0.88

e9/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

2.92

4.60

1.6

2.2

1.09

1.16

e9/l

0.13

Hyperplasia of prostate

189

761

1.41

4.60

2.7

2.5

1.14

1.05

e9/l

0.65

175

704

Other and unspecified bullous disorders

4.65

4.60

1.2

1.9

1.14

1.17

e9/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CD3 cells [#/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS